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Abstract
Coordination of gene expression in eukaryotes involves several hierarchical regulations in 
response to internal and environmental changes. DNA topology, the fundamental control for 
DNA functions, is regulated through different DNA topoisomerases such as Topoisomerase 
1. These enzymes, having the ability to cut one or two strands of DNA, relief torsional 
stresses that are caused by processes such as replication, transcription, recombination and 
repair. Recently, DNA negative supercoiling is associated with the formation of non B-DNA 
structures such as G-quadruplexes and R-loops that may have functional roles in gene 
regulations. 
This thesis is, hence, a continuation of an on-going research project which has been 
investigating the role of human Top1 during transcriptional consequences associated with 
Top1 inhibition by CPT (a specific Top1 poison) in human cell lines. We investigate the 
interaction of Top1 with G-quadruplex in cancer cells using pharmacological tools, ie. CPT 
inhibitors and G4 binders (binds and stabilizes G4 structures).
Previous findings demonstrate that Top1-DNA cleavage complexes (Top1ccs) trigger an 
accumulation of antisense RNAPII transcripts specifically at active divergent CpG-island 
promoters in a replication independent and Top1 dependent manner. A burst of Top1ccs, 
parallels the transient increase of R-loops is reported in these promoters and transcribed 
regions; indicating a response pathway leading to transcription-dependent genome instability 
and altered transcription regulation. 
Using different cancer cell lines of colon and osteo origins, we show that they display 
different sensitivity to CPT that is independent from Top1 level. The cell lines also show 
different response to G4 binders. To look at the interactions between Top1 and G4, we show 
that co-treatment with G4 binders potentiate the cell cytotoxicity of CPT regardless of the 
treatment sequences. Potentiation is indicated by a reduced inhibition concentration (IC50)
with a more profound cytotoxicity in CPT-resistant cell lines, HCT15 and U2OS. We hence, 
show the interactions between Top1inhibitor and G4 binders. This is further supported by 
the presence of G4 motifs as determined by computational analysis on 225 genes with CPT-
iv
induced antisense transcription. G4 motifs are present mostly 5000 bp upstream from 
transcription start site and notably lower in genes. Comparisons between genes with no 
antisense transcription and genes with antisense transcription show that G4 motifs in this 
region are notably lower in the genes with antisense transcripts. 
Since CPT increases negative supercoils at promoters of intermediate activity, we then 
demonstrate that the formation of G4 is also increased in CPT-treated cells. Suprisingly, 
formation of G4 is regulated in parallel to the transient stabilization of R-loops, indicating a 
role in response to stress caused by CPT. Moreover, G4 formation is highly elevated in 
Pyridostatin treated cells, which previous study shows increased formation of γH2Ax foci.
This effect is also seen in the CPT-resistant cell lines, HCT15, indicating that the formation 
is a general event in response to CPT. We also show that R-loop formation is greatly 
increased in Pyridostatin treated cells. In order to study the role of R-loops and G4 structures 
in Top1cc-dependant repair pathway, we inhibited tyrosyl-phosphodiestrase 1 (TDP-1) using 
a TDP-1 inhibitor. Although, we have not obtained a similar kinetics as seen in the 
formation of R-loops and G4, we show that prolonged TDP-1 inhibition show a small 
changes in their formation, if any. It is however, further experiments need to be performed to 
establish whether or not TDP1 has any role in G4 and R loop formation, in particular we 
need to assess the effects of TDP1 inhibitor on G4 and R- loop levels induced by CPT and 
pyridostatin.
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Chapter 1 
Introduction 
 
A typical DNA structure consists of two complementary polynucleotide chains that 
are multiply interwound, forming a diameter of 20A double helix as coined by Watson and 
Crick in 1953. This form, also known as the B-DNA, is a right-handed helix with a period of 
approximately 10.5 base-pairs per turn at physiological conditions. Being in relaxed form, 
the B-DNA is kept at its lowest energy state. This underwound state of DNA, is referred as 
negatively supercoiled. Although in the beginning the high level of DNA supercoiling was 
seen as physicochemical tricks that were not directly clear to biology, it has later become 
clear that negatively supercoiled DNA is homeostatically maintained to provide means for 
the genome to be compacted and also allowing a mechanism where the access of genetic 
information is tightly regulated. When a DNA helicase separates the two strands of a (−) 
supercoiled DNA, the remaining DNA initially becomes relaxed, however further strand 
separation causes the accumulation of positive (+) supercoils. 
The topological properties of DNA are defined by the linking number (Lk) which 
refers to the number of times the two helical strands are interwound. The Lk for a relaxed 
molecule, termed Lk0, is equal to the number of base pairs divided by the period of the 
DNA helix. Most theoretical and computational modeling of DNA assumes that the double 
helix behaves as an isotropic elastic rod.  Due to its compacted structure, local melting of the 
supercoiled structure is required to allow access to DNA for transcription and replication. 
This led to the DNA to be overwound or having a positively supercoiled DNA helix.  of the  
helix changes  the  twist (Tw),  a  parameter  describing the number of times the individual 
strands coil around the helical axis. If the DNA behaves as an isotropic elastic rod, then as 
the value of Tw increases, the associated torque should increase linearly. When Tw reaches 
a critical density, the molecule bends to form plectonemic structures in which the double 
helix coils about itself, a property known as writhe (Wr).  The coiling of the double helix 
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about itself is more commonly known as supercoiling. The sum of Tw and Wr is equal to the 
linking number such that: 
Lk = Tw + Wr 
Any change in the linking number must result in a change in the twist and/or writhe such 
that: 
∆Lk = ∆Tw + ∆Wr 
As the writhe of a relaxed molecule is equal to zero, hence: 
∆Wr = Wr - 0 = Wr 
To better understand the model DNA supercoiling, one can use a piece of rubber tubing. 
DNA is a right-handed helix, i.e. the helix spirals in a clockwise direction. Therefore, to 
simulate the effects of overwinding (positive supercoiling) one can introduce clockwise 
twist into the tubing. When sufficient twist is added, the tubing coils about itself analogously 
to DNA writhe. Positively supercoiled DNA coils about itself in a left-handed direction. In 
contrast negatively supercoiled DNA assumes a right-handed superhelical structure.  
Mathematically, this means that the value of Lk is lower than that of Lk0. The negative 
linking difference, ∆Lk, is defined by: 
∆Lk = Lk − Lk0 
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Figure 1. Diagrammatic depiction for DNA supercoiling. a) DNA supercoiling at relax state; b) 
DNA supercoiling with stress induced by topoisomerase; c) DNA supercoiling at a relax state with 
partial melting and producing a negatively coiled structure [Human Biology, Benjamin Cummings, 
Pearson 2004]. 
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Figure 2. Topology of closed circular DNA. a) Sign convention for DNA crossings in closed-
circular DNA. The convention corresponds to the normal right-hand rule in chemistry and physics: a 
left-handed crossing is counted as negative whereas a right-handed crossing is counted a positive. b) 
Conversion of relaxed DNA into negatively and positively supercoiled DNA. The description of 
supercoiling, the linking number, can be computed from one-half the sum of signed crossings of the 
red and black strands. In the case of relaxed DNA there is no writhe and the linking number, Lk is 
equal to the twist number, Tw. In negatively supercoiled DNA, reduction of Lk below Tw gives rise 
to right-handed interwound supercoils, or negatively writhe. Conversely, incrementing Lk above Tw 
generates left-handed interwound supercoils and positive writhe [Human Biology, Benjamin 
Cummings, Pearson 2004]. 
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1.1  Biological importance of being underwound   
 
Negative supercoiling serves as a store of free energy and provides the energy for 
localized, controlled melting of the DNA duplex to allow access of DNA polymerases, RNA 
polymerases, repair factors and recombinases to the internal nucleotide sequence. In addition 
to accessing these sequences, many DNA metabolic processes have additional specific DNA 
conformational requirements. For example, transcriptional regulation, through enhancers, 
and synapsis during site-specific recombination both require that distant DNA sites come in 
close physical proximity. All these require topological regulations to underwind (to facilitate 
strand separation) and overwind (to inhibit strand separation). Topological regulation in the 
bacterial genome is enzymatically regulated by a group of Topoismerases, namely DNA 
gyrase, Topoisomerase 1 and Topoisomerase IV. DNA gyrase introduces negative supercoils 
into DNA and Topoisomerase I relaxes the highly superhelical tension. Topoisomerase IV  
resolves DNA knots and catenanes, an important feature for genome duplication and 
segregation. In the eukaryotic where the regulation is much less clear, regulation of DNA 
topology has been based on the twin supercoiling domain model proposed by Liu and Wang 
in 1987 to explain how transcription by RNA polymerase can be used to stimulate DNA 
supercoiling. The model postulates that rotation of the RNA polymerase-RNA complex 
around the DNA helical axis during transcription becomes increasingly difficult as the size 
of the growing RNA chain increases. The rotation reaches a critical point when it is more 
feasible energetically to rotate the DNA on its axis rather than rotate the transcription 
complex and any associated proteins around the DNA. Further translocation of the 
polymerase generates transient DNA supercoils, positive supercoils in front of the 
polymerase and negative supercoils behind it.  
 
1.2  DNA topoisomerases       
 
DNA cleavage by all topoisomerases is accompanied by the formation of a transient 
phosphodiester bond between a tyrosine residue in the protein and one of the ends of the 
broken strand. In this way they regulate DNA superhelicity and solve topological problems 
arising during DNA metabolism. DNA superhelicity is influenced by topoisomerases I and 
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II (Top1p and Top2p), encoded by the TOP1 and TOP2 genes. Topoisomerases are 
classified into two main subfamilies in function of structural and mechanistical differences: 
type I cleaves only one strand of the double helix and type II cleaves both strands to 
generate a double-strand break. Type I topoisomerases are further classified in type IA 
subfamily members if the protein link is to a 5’ phosphate and type IB subfamily members if 
the protein is attached to a 3’ phosphate. Further division of the type II subfamily in IIA and 
IIB is based on structural considerations. Members of the same subfamily are similar in 
structure and mechanism of action [Wang, et. al., 2002; Champoux, et. al., 2001]. 
1.2.1 Type IA 
The topoisomerases in the type IA subfamily share several properties. They are all 
monomeric (except Methanopyrus kandleri reverse gyrase) and require Mg2+ for the DNA 
relaxation activity. The type IA enzymes catalyse DNA strand passage by an ‘enzyme-
bridging’ mechanism, in which the DNA ends, which are created in the DNA breakage 
reaction, are bridged by the topoisomerase [Lima et. al., 1994]. Movements of the enzyme-
bound DNA ends relative to each other mediate the opening and closing of the DNA gate 
[Lima et. al., 1994]. During the cleavage of a DNA strand, a covalent attachment of one of 
the DNA ends to the enzyme is formed through a 5’ phosphodiester bond to the active amino 
acid tyrosine. Negative supercoils are substrates for the relaxation reaction but relaxation 
requires an exposed single-stranded region within the substrate DNA to complete the 
reaction [Wang et. al., 1996]. Bacterial DNA topoisomerases I and III, Yeast DNA 
topoisomerase III, Drosophila melanogaster DNA topoisomerases IIIα and IIIβ, Mammalian 
DNA topoisomerases IIIα and IIIβ are some of the representative from this subfamily [Wang 
et. al., 2002].  
The E. coli Top1, for example, can be divided into three domains.  
 N-terminal domain, composed of the first 582 amino acids, corresponds to a core 
“cleavage/strand passage” domain containing the active site tyrosine at position 319; 
 Zn2+-binding domain, consisting of 162 amino acids that contain three tetracysteine 
motifs. This region of the protein is required for the strand passage reaction; 
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 C-terminal domain, enriched with basic amino acids and contributes to substrate binding 
preferentially for single-stranded DNA [Zhang et. al., 2001].  
 
While the N-terminal domain, containing the catalytic tyrosine, is highly conserved, the 
Zn2+-binding domain is not.  Notably, both yeast and E. coli topoisomerases III lack a Zn2+-
binding domain, while the human Top IIIβ has an incomplete Zn2+-binding domain. 
Further, all the Tops IIIα, even from phylogenetically different groups, possess a highly 
conserved set of eight CXXC motifs that could correspond to four zinc fingers [Wang et. al., 
2002].  
 
Figure 3. a) Mechanism of action of type IA topoisomerases. On transient breakage of a DNA 
strand, the 5’end is covalently attached to the active-site tyrosyl group (red circle) in the ‘lid’ of the 
enzyme, while the 3’end is noncovalently bound to the enzyme. The opening of the gate allows the 
passage of another DNA strand (green circle) [Wang et. al., 2002]. b) Crystal structures of E. coli 
Top 1 [Champoux et. al., 2001]. 
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1.2.2  Type IB 
This subfamily of topoisomerases is composed of three classes of enzymes: the 
topoisomerases I found in all eukaryotic cells, the poxvirus topoisomerases (vaccinia 
enzyme), and the prokaryotic Top V from Methanopyrus kandleri [Wang et. al., 2002]. They 
share no sequence or structural homology with other known topoisomerases. The type IB 
subfamily members can relax both positive and negative supercoils, and relaxation goes to 
completion, hence, negating the need for partially single-stranded DNA as substrate. The 
type IB topoisomerases form a covalent intermediate in which the active site tyrosine 
becomes attached to the 3’ phosphate end of the cleaved strand. The enzymes contain no 
bound metal ions, and DNA relaxation does not require Mg2+ [Champoux et. al., 2001]. 
The type IB enzymes act by a ‘DNA rotation’, rather than by an ‘enzyme-bridging’ 
mechanism. When a DNA-bound type IB enzyme transiently cleaves one of the DNA 
strands, only the side of the DNA double helix that is upstream of the nick, the side 
containing the protein-linked 3’ end of the broken strand, is tightly bound to the enzyme. 
Interaction between the downstream side of the dsDNA and the enzyme is mostly ionic 
physiologically, presenting a low barrier to a 75° rotation between the DNA and protein. The 
DNA segments that flank a transient nick can therefore rotate relative to each other by 
turning around one of the single bonds that opposes the nick [Champoux et. al., 2001; Wang 
et. al., 2002].  
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Figure 4. The human Top1 controlled rotation mechanism. A highly negatively superhelical DNA is 
converted to a less supercoiled state. Human Top1 is rendered as a bilobed structure with core 
subdomains I and II forming the “cap” lobe, cyan. The “catalytic” lobe is magenta. 30° intervaling 
DNA rotation states are different-colored in step (D). Small movements of the protein (small arrows) 
may be allowed during the events of controlled rotation [Stewart et. al., 1998]. 
 
Human DNA Top I, a 91-kDa protein, is subdivided into four distinct domains:  
 The N-terminal domain is a 214 amino acids sequence and is a hydrophilic, unstructured, 
and highly protease-sensitive region of the protein. It is dispensable for relaxation activity 
in vitro and presents four nuclear localization signals and sites for interaction with other 
cellular proteins, including nucleolin, SV40 T-antigen, certain transcription factors, p53, 
and the WRN protein.  
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 The core is a 421 amino acid domain that binds DNA and contains all of the catalytic 
residues except the active site tyrosine suggesting to be highly conserved. It has further 
subdivided into core subdomains I, II, and III.  
 A protease-sensitive and poorly conserved linker domain comprising 77 amino acids 
connects the core domain to the 53 amino acid C-terminal domain. It is dispensable and 
assumes a coiled-coil structure in the 3D protein. 
 The C-terminal domain that contains the active site such as the catalytic Tyr723. 
 
In the 3D structure, the protein assumes a “lobulated” conformation. One of these lobes 
comprises core subdomains I and II and forms the “cap” of the protein. The front end of the 
cap consists of a pair of long α-helices in a V-shaped configuration. The other lobe forms a 
base that gets in touch with the DNA and consists of core subdomain III and the C-terminal 
domain. This second lobe is connected to the cap by a long α-helix labeled the “connector”. 
On the side opposite to this α-helix is pair of opposing loops called the “lips”. Opening and 
closing of the protein clamp during DNA binding and release must involve the breaking of 
this interaction between the lips and the lifting of the cap away from the base [Stewart et. al., 
1998].  
The enzyme has a strong preference for binding to supercoiled DNA over relaxed DNA and 
nicks the DNA with a preference for a combination of nucleotides that extends from 
positions -4 to -1. The preferred nucleotides in the scissile strand are 5’-(A/T)(G/C)(A/T)T-
3’ with the enzyme covalently attached to the -1 T residue [Jaxel et. al., 1991]. Other 
protein-DNA interactions, in addition to the Tyr723, play an important role in cleavage site 
selection, as residues Arg488, Arg590, His632 of human enzyme [Interthal et. al.,2001]. 
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Figure 5. a) Structure of human Top I. Core subdomains I, II and III are colored yellow, blue and 
red, respectively. The linker and C-terminal domain are shown in orange and green, respectively. 
The active site tyrosine is shown in black ball and stick. The long α-helix that connects the cap to the 
base of the core is labeled “Connector” [Champoux et. al., 2001]. b) Schematic of Type IB enzymes 
where an intermediate between a DNA fragment and a type IB DNA topoisomerase is shown. The 3' 
end of the broken DNA scissile strand is covalently linked to the active-site tyrosyl group (Y) of the 
enzyme (red circle) [Wang et. al., 2002]. 
 
1.2.3 Type II 
In contrast to the type I enzymes, the type II DNA topoisomerases are ATP-
dependent dimeric enzymes. The mechanism of action of these enzymes involves covalent 
attachment of each subunit of the dimer to the 5’ end of the DNA through a phosphotyrosine 
bond. The dimeric enzymes bind duplex DNA and cleave the opposing strands, while a 
conformational change pulls the two ends of the cleaved duplex DNA apart to create an 
opening in what is referred to as the gated or G-segment DNA. A second region of duplex 
DNA from either the same molecule or a different molecule, the transported or T-segment, is 
passed through this open DNA gate. This feature of the reaction explains why the linking 
number is changed in steps of two when the supercoiling of a circular DNA is changed. 
Besides ATP hydrolysis, the reactions also require Mg2+ [Champoux et. al., 2001]. The 
crystal structures of several members reveal that the active site tyrosines are situated in a 
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helix-turn-helix (HTH). As with the type IB enzymes, a highly conserved arginine residue is 
implicated in catalysis by its close proximity to the active site tyrosine [Berger et. al., 1996].  
Within type IIA are Bacterial gyrase (DNA Top IV), Phage T4 DNA topoisomerase, Yeast 
DNA Top II, Drosophila DNA Top II and Mammalian DNA Tops IIα and IIβ.  
All prokaryotic type II topoisomerases contain two different subunits and are therefore 
heterotetrameric in structure, whereas the eukaryotic enzymes are homodimers. Among all 
of the type II enzymes, DNA gyrase stands alone as the only enzyme capable of using the 
energy from ATP hydrolysis to introduce negative supercoils into the DNA. These enzymes 
use ATP hydrolysis to transport one DNA double helix through another, passage that reflects 
in several topological transformations, including catenation and decatenation of dsDNA 
rings, and the relaxation of positively or negatively supercoiled DNA [Berger et. al., 1996]. 
Different members of the type II family can be distinguished by their relative proficiency at 
DNA relaxation versus decatenation/catenation, likely to reflect their specialized roles in the 
cell [Wang et. al., 2002; Champoux et. al., 2001].   
 
1.3  Modulation of Topoisomerase 
1.3.1  DNA replication  
The initiation of replication begins with the opening a DNA region by unpairing the 
DNA strands. In E. coli plasmid-replication systems, a negatively supercoiled template is 
usually required for initiation, hence, requiring the ability of bacterial gyrase to introduce 
negatively supercoil for the initiation of DNA replication. In yeast, either TopI or TopII, 
both of which can relax positive and negative supercoils, are required for their functions in 
the movement of growing forks [Wang et. al.,1996]. 
The topological consequences of an advancing replication fork, and the roles of different 
DNA topoisomerases, depend on whether the replication machinery is allowed to rotate in 
the cellular milieu. If the replication machinery cannot rotate around the helical axis of the 
unreplicated DNA, it can force the helical intertwines of the DNA and the DNA becomes 
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positively supercoiled ahead, while the replicated bubble becomes progressively larger 
behind. In contrast, if replication machinery is allowed to rotate, the positive supercoils 
ahead of it might be redistributed to the region behind it, leading to intertwining of the pair 
of replicated DNA segments and positive supercoiling of the unreplicated DNA behind the 
fork [Wang et. al., 2002]. 
The mechanisms of the various subfamilies of DNA topoisomerases predict that the positive 
supercoils that are generated by replication can be removed by a type IB or a type II enzyme 
[Wang et. al., 2002; Champoux et. al., 2001]. Because of the inefficiency of type IA 
enzymes at removing positive supercoils that do not have a pre-existing single-stranded 
region in the DNA, they are expected to be less suitable than type IB or type II enzymes for 
solving the topological problems that are associated with DNA chain elongation in 
replication [Wang et. al., 2002]. 
 
1.3.2  Transcription  
The best example of supercoiling generating process is transcription.  Due to the 
huge molecular mass of the RNA polymerase, the DNA template is forced to rotate around 
its axis as the double helix passes through the transcriptional machinery [Liu et. al., 1987]. 
The upstream DNA becomes untwisted, while the downstream DNA becomes positively 
supercoiled. This enormous torsional stress might inhibit an efficient transcription 
[Capranico et. al., 2010], hence, playing its role in modulating gene expression. DNA 
torsional tension may coordinate also local or regional transcription by modulating the 
stability of protein-DNA interactions, e.g. interactions between transcription machinery 
factors and promoters or coding regions [Capranico et. al., 2010].  
 DNA topoisomerases are required to restore the topological conformation of the 
DNA. It is however, the requirement for DNA topoisomerases in transcription depends on 
the ability of the transcription apparatus (which includes the RNA polymerase, proteins 
associated with the polymerase, and the nascent transcript and its associated proteins) to 
rotate. In transcription, the elongation of a nascent transcript resembles those of the 
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elongation step in replication except that it does not involve a continuous separation of the 
parental DNA strands, hence, modulating the local supercoiled state of the DNA, rather than 
fulfilling a topological necessity [Wang et. al., 2002]. Another important factor which is the 
distribution of promoters in divergent orientation can reinforce DNA supercoiling upstream 
transcription start sites by untwisting the double helix and directly inducing plectonemes 
[Seila et. al., 2008]. The type IIA enzymes in prokaryotes, especially DNA gyrase, remove 
positive supercoils, whereas the type IA enzyme DNA Top I is important in the removal of 
negative supercoils [Wang et. al., 1996]. In E. coli topA mutants, the lack of DNA Top I 
induces an excessive negative supercoiling, a condition favours base-pairing between the 
nascent RNA and its template strand (‘R-looping’), a condition which is often implicated in 
genome instability [Drolet et. al., 1995].  
In the eukaryotes, DNA Top I is present in actively transcribed regions [Wang et. al., 
2001], mainly functions to relax transcription-generated DNA supercoils [Wang et. al., 
2002]. Top I is also able induce hyperphosphorylation of Rpb1 subunit of the RNAPII to 
facilitate their escape from pausing sites. This escape requires the formation of an active 
TFIID–TFIIA protein complex on the promoter and could thus act as co-activator 
[Capranico et. al., 2010; Baranello et. al., 2010; Wang et. al., 2002]. Silencing the Top1 
gene causes genome instability in human cells as chromosomal translocations are increased, 
as a consequence of unresolved topological problems arising when the replication forks 
encounter translocating transcriptional machineries [Capranico et. al., 2010]. 
Physiologically, in the eukaryotes, the DNA is compacted into nucleosomes as a means of 
packaging into the nucleus. The compacted DNA supramolecules are inaccessible to 
enzymes and proteins (polymerases) for transcriptopn initiation but also restricts 
transcription elongation along the DNA. Because of the strong binding energy between 
nucleosomes and DNA, chromatin remodelers are required to disrupt or to slide 
nucleosomes, hence, providing a mean for transcription regulation. Special ATP deoendent 
protein complexes called chromatin remodelers are able to remove or slide nucleosomes. 
Notably, in vitro experiments have shown that these chromatin remodeling activities directly 
generate torsional stress of DNA in the presence of nucleosomes which has to be solved by 
DNA topoisomerase [Baranello et. al., 2010; Wang et. al., 2002]. Additionally, in cases 
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where a stably base-paired region between a nascent RNA and its template strand has 
formed, a topoisomerase-mediated untwining of the transcript from the template strand, 
rather than the nucleolytic removal of the DNA-bound RNA by RNase H, could also be used 
to salvage the transcript [Pommier et. al., 2006; Drolet et. al., 1995].  
 
1.3.3  DNA recombination 
Resolution of an intermediate of recombinational repair is characterized by 
topological tension, can be solved by DNA topoisomerases [Wang et. al., 2002]. The role of 
these enzymes in the modulation of recombination has been widely investigated pointed to 
an important role by the type IA enzymes. Escherichia coli cells that lack both type IA DNA 
topoisomerases are non-viable. Additionally, investigations have shown links between this 
lethal genotype to a gene involved in the process of recombination, the recA gene. There are 
indications that type IA enzymes may be involved in RecA-mediated recombination and that 
they can specifically resolve recombination intermediates before chromosome segregation 
[Zhu et. al., 2001]. Also Top IIB might be involved in recombination, and more exactly, in 
meiotic recombination. It presents different homologues in various organisms, of which the 
SPO11 gene product of S. cerevisiae, which binds in a covalent manner to the 5’ends of 
broken DNA, found in meiotic recombination hot-spots [Keeney et. al., 2008]. 
 
1.3.4 Role of Topoisomerases in the chromosomal topological organization 
Chromatin compaction, chromosome segregation, and DNA topology are intricately 
interrelated both in prokaryotes and eukaryotes [Nordstrom et. al., 2001]. 
As the unreplicated segment of parental DNA becomes very short, a type II DNA 
topoisomerase is required to convert the residual intertwines between the parental strands 
into intertwines between the newly replicated daughter molecules so that the segregation of 
the newly replicated molecules can be established. Evidences show that in E. coli and yeast, 
DNA topoisomerases II are indispensable in chromosome segregation [Wang et. al., 1996]. 
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The eukaryotic Top II is involved in chromatin and chromosome condensation during 
mitosis and in apoptotic chromatin condensation [Durrieu et. al., 2000]. Further, mammalian 
Top II has a structural role in chromosome. Its α-isoform, for instance, is a main non-histone 
protein in the axial core or scaffold of metaphase chromosomes [Wang et. al., 2002]. 
However, this role remained open for debate as neither of the Top II isomers are not 
immobile structural components of the chromosomal scaffold [Christensen et. al., 2002].  
Chromosome condensation and decondensation is a key event not only during chromosome 
segregation but also in the fine tuning of gene expression in higher eukaryotic beings. In 
general, whenever a long chromatin fiber undergoes a structural change, any accompanying 
changes in its twist could require the catalytic action of one or more DNA topoisomerases 
and in some processes, chromatin remodeling is necessary [Capranico et. al., 2010]. The 
association of Drosophila DNA Top II and human DNA Top IIβ with ATP-dependent 
chromatin remodeling complexes has been reported. A main Top1 function may be the 
regulation of nucleosome remodeling by modulating the torsional tension generated by the 
assembly and/or disassembly of nucleosomes [Wang et. al., 2002]. In support to this, 
deletion and mutation in the Top1 gene sees an up-regulation in gene expression as well as 
increased acetylation of core histones at telomeric and sub-telomeric regions in S. cerevisiae 
[Lotito et. al., 2008; Wang et. al., 2002]. 
 
1.4 Camptothecin: a specific Topoisomerase inhibitor 
The immense interest in topoisomerases in recent years derives not only from the 
recognition of their crucial role in managing DNA topology, but also because a wide variety 
of topoisomerase-targeted drugs have been identified, many of which generate cytotoxic 
lesions by binding to the interface between Top1 and DNA, thus, trapping the enzymes in 
covalent complexes on the DNA which inhibit the function of Top1 to relegate DNA after 
cleavage reaction [Liu et. al., 2000]. These features enable topoisomerase an interesting 
therapeutic target in clinical use. 
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Camptothecin (CPT) is a natural product that was isolated from the Chinese tree 
Camptotheca acuminata by Wall and Wani and was shown to inhibit the growth of cancer 
cells in cell culture [Wall et. al., 1966]. It penetrates vertebrate cells readily and targets Top1 
within minutes of exposure to low or even sub-micromolar drug concentrations. 
Camptothecin is a 5-ring heterocyclic alkaloid that contains an hydroxylactone within its E-
ring that is unstable at physiological pH. The active lactone form is in equilibrium with its 
inactive carboxylate derivative, characterized by an open E-ring (Figure 7) [Pommier et. al., 
2006]. 
 
Figure 6. Structure of CPT and CPT E-ring [Pommier et. al., 2009] 
 
CPT specifically targets Top1. Structural studies established that camptothecin interacts with 
active site amino acid residues and DNA base pairs at the cleavage site, preventing strand 
religation and therefore increasing the half-life of the Top1–DNA cleavage complex 
(Top1cc). Formation of the cleavage complex is a critical event during the cell cycle since 
cell vitality is seriously compromised by poisoning this complex [Pommier et. al., 2009]. 
This effect is highly reversible both in vitro and in vivo [Capranico et. al., 2010]. Although 
reversible, it becomes lethal when collisions occur between Top1cc and an advancing 
replication fork, converting the single-strand breaks into irreversible double-stranded DNA 
(dsDNA) breaks and imminent cell deaths through the activation of DNA damage 
checkpoints [Capranico et. al., 2010].  
In the less studied aspect of CPT effect, the early effect inhibition of Top1 by CPT has been 
seen to introduce topological stress and hence, a major reorganization of chromatin is in 
place in response to Top1 mediated DNA damage.    
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Duann et. al. (1999) observed an increased in the linking number of the episomal DNA in a 
Top1-dependent manner and within 3 min of CPT treatment, indicating that Top1 is actively 
involved in maintaining the negatively supercoiled state of episomal DNA. Since Top1 must 
mainly remove positive supercoils, and as a consequence of CPT effect, inhibition of Top1 
by camptothecin would result in more positively supercoiled DNA. Further support provided 
by single molecule manipulation which monitored the dynamics of human Top1 in the 
presence of Topotecan, an analog to CPT. The uncoiling activity of Top1 due to topotecan 
effect sees a 20-fold slower and hinders the removal of positive supercoiling. It is shown; 
however, the camptothecin-induced chromatin reorganization only alters nucleosome 
conformation and/or position along the studied DNA regions but not being removed from 
DNA template [Capranico et. al., 2010; Wang et. al., 2002; Duann et. al., 1999]. One model 
suggested that Top1 inhibition in vivo lead to the transient wave of positive torsion 
downstream of Pol II destabilizes genic nucleosomes to allow progression, and the transient 
negative torsion stabilizes nucleosome formation behind Pol II to maintain chromatin 
structure. This supports a balance between destabilization of nucleosomes for Pol II passage 
and maintenance of chromatin structure for chromosomal integrity. 
Since CPT readily penetrates into cells, its effects is seen as early as the first 2 minutes of 
cell treatment with 10uM, activating the initiation step of transcription [Marinello et. al., 
2013] and the expression of certain genes in human cells [Collins et. al., 2001]. CPT triggers 
hyperphosphorylation of the largest subunit (Rpb1) of RNA polymerase II (Pol II) which 
apparently occurs on Ser-5 residues of heptapeptide repeats of the carboxy-terminal domain 
(CTD) possibly mediated by Cdk7, component of TFIIH [Sordet et. al., 2008; Khobta et. al., 
2006]. In addition to this CPT-induced effect is reported to contribute to the disruption of the 
large inactive positive elongation factor b (P-TEFb) complex, which is kept an inactive state 
in the multisubunit 7SK snRNP. Disruption of P-TEFb releases free active P-TEFb complex 
(containing the Cdk9 subunit) that correlates with a concomitant hyper-phosphorylation of 
RNAPII, which in turn alters the levels and distribution of the RNAPII along transcribed 
genes [Amente et. al., 2009]. 
Consequently, chromatin-bound Pol II is redistributed along transcribe genes in human 
cancer cells by enhancing the escape of Pol II from promoter proximal pausing sites [Khobta 
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et. al., 2006].  In HIF-1 α gene CPT stimulates antisense transcription in a Cdk 9/7 
dependant manner. Consequently, this may lead to the de-repression of antisense 
transcription and reduced synthesis of mRNAs [Baranello et. al., 2010].  
It has been proposed that a sustained camptothecin interference with Pol II regulation that 
increases its pausing efficiency, may eventually lead to a general transcriptional stress which 
involves a more accessible chromatin conformation through histone modifications, 
specifically at transcribed loci in human cells. CPT causes a decrease of histone H1, and 
acetylation of H3 and H4 on the gene cluster of human chromosome 1 but not at repressed 
α-satellite DNAs [Khobta et. al., 2006]. Unlimited to HIF-1α, the effect of CPT is further 
demonstrated in a genome-wide scale. CPT-stabilized Top1ccs is shown to have a specific 
and dynamic impact at divergent CpG-island (CGI) promoters in human cells. CPT 
enhances the levels of antisense RNAPII transcripts upstream of transcriptional start site 
(TSS) at divergent CGI promoters [Marinello et. al., 2013]. This effect depends on cellular 
Top1 levels while is independent from DNA replication. Divergent promoters have been 
reported in several eukaryotic cells raising the question of how this process contributes to 
regulation of gene activity and chromatin structure. Divergent CGI promoters may constitute 
a set of gene control regions highly sensitive to exogenous and endogenous perturbation of 
Top1 activity.  
Moreover, Top1 can undergo protein degradation within 1 h of camptothecin treatments in 
certain cancer cells. The removal of Top1 cleavage complexes and DNA break processing 
are transcription-dependent, and coupled to ubiquitination and degradation of Top1 and Pol 
II through the 26 S proteasome pathway [Sordet et. al., 2008; Desai et. al., 2003]. Further, 
blocking of Top1 activity by camptothecin promotes an increase of local negative 
supercoiling behind the transcriptional apparatus thus stabilizing R-loop structures, 
especially at nucleoli and mitochondria, and the kinetic closely parallels Top1cc formation. 
These non-B structures may increase genome instability. Notably, in bi-directional 
promoters, the rate of transcription-generated negative torsional tension is necessarily higher 
as divergent RNAPIIs elongate in different directions and this event could further ease R-
loop formation [Marinello et. al., 2013; Sordet et. al., 2009]. Top1 inhibition by 
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camptothecin has also been reported to block the SR-kinase activity of Top1; in this case 
splicing might be inhibited because of ASF hypophosphorylation [Pommier et. al., 2006].  
In this scenario, CPT not only makes clear its antitumor effect by way of DNA replication 
and DNA damage checkpoints but can also interfere with transcription regulation, that can 
lead to alterations of gene expression patterns that may be relevant for cancer therapy, e.g. 
HIF-1α [Marinello et. al., 2013; Capranico et. al.,  2010].  
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Figure 7. a) Conversion of Top1cc into DNA damage by replication-fork collision. The consequence 
is a replication double-strand break (RepDSB). b) Conversion of Top1 cleavage complexes into 
DNA damage by transcription: the RNA–DNA duplex prevents the religation of the Top1cc, and 
Top1 inhibition leads to an accumulation of negative supercoiling that could promote the formation 
of an R-loop. Inhibition of Top1 SR-kinase activity would also inactivate splicing because of ASF 
hypophosphorylation [Pommier et. al., 2006]. 
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1.5  Non B-form DNA structures  
 
Non cell techniques such as circular dichroism and x-ray crystallgraphy has enabled 
the discovery secondary structures in DNA, which since its revelation in 1953 has been 
predominantly B-form (B-DNA) and right-handed double helical structure. Secondary DNA 
structures containing regions of single-stranded DNA that can adopt a variety of alternative 
conformations based on particular sequence motifs and interactions with different proteins. 
Cruciforms, Z-DNA, triplexes and G-quadruplexes are some of the non B-form secondary 
structures. Their non-random presence in the DNA regions involved in regulations has 
sparked increasing interests on their functional roles in vivo. 
 
1.5.1  G-quadruplex motifs and structures 
G-quadruplex structures are stacked nucleic acid structures that can form within 
specific repetitive G-rich DNA or RNA that have sequence motif  
G≥3NxG≥3NxG≥3NxG≥3. There are >375,000 predicted G4 motifs in the human genome 
and >1,400 G4 motifs have been predicted in Saccharomyces cerevisiae. The motif confers 
the ability to form a four stranded structure with two adjacent guanine are bonded by the 
Hogsteen hydrogen forming a square planar (G-quartet). Stacked G-quartets form a G4 
structure, and the intervening sequences are extruded as single-strand loops except in 
tetramolecular G4 structures which may lack loops. The sequence and size of the loop 
regions varies, usually small (1–7 nucleotides (nt)). Smaller loops and longer G-tracks result 
in more stable G4 structures. This structure is stabilized by monovalent cations that occupy 
the central cavities between the stacks, neutralizing the electrostatic repulsion of inwardly 
pointing guanine oxygens. G-quadruplexes are stabilized by K+ or Na+ ions at physiological 
temperature and pH in vitro. 
G4 motifs are abundant in specific chromosomal domains, genomic regions, and genes. In 
human cells, the telomeres, rDNA, immunoglobulin switch regions (S regions), some 
variable number tandem repeats (VNTRs), and some single copy genes are all enriched for 
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G4 motifs,  meiotic double-strand break (DSB) sites, and transcriptional start sites (TSSs; 
often near promoters), hence, providing a considerable potential repertoire for formation of 
diverse structures that may correlate with specific functions.  
1.5.2  Chromosomal location of G4 motifs.  
G4 motifs found on the chromosomal locations forms very stable G4 structures of 
different topologies and are classified into various groups based on their orientation in the 
DNA strand. Their orientation can be parallel, antiparallel or hybrids and within one strand 
(intramolecular) or from multiple strands (intermolecular), and various loop structures. 
These features however, depended on several factors including the length and sequence 
composition of the total G4 motif, the size of the loops between the guanines, strand 
stoichiometry and alignment 11–13, and the nature of the binding cations.     
Zhang et al (2013) using in vitro transcription method, reported that the formation of G4 was 
observed in the upstream but not downstream of TSS, which can be few thousands base 
pairs away from the promoters. G4 forms disregard to its distance of a travelling polymerase 
but rather the speed at which it is traveling [Zhang et. al., 2013]. This has provided evidence 
to support computational studies in various organisms have revealed that G4 motifs are not 
randomly located within genomes, but rather they tend to cluster in particular genomic 
regions. Moreover, the G4 motifs are seen enriched at the 5’ end of the DNA among warm-
blooded animals (Figure 8).  
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Figure 8. Distribution of PQS occurrence in the 5000bp region flanking the 5’ and 3’ end genes 
[Zhang et. al., 2013]. Enrichment of G4 motifs at the 5’ end of chromosomes in higher organisms 
but not in lower organisms. 
 
1.5.3  Telomeric G4 structures 
Telomeres are special structure at the extreme ends of eukaryotic chromosomes, 
composing of a DNA component and multiple protein components. They provide 
protections from enzymatic end- degradation. The DNA component of human telomere 
structure is a long stretch of double-stranded DNA composed of a hexanucleotide DNA 
repeat sequence (5’-T2AG3-3’ in veterbrate and 5’-T4G4-3’ in certain ciliated protozoans 
such as Stylonychia lemnae). In addition, all telomeres terminate with a 3’ single-stranded 
G-rich DNA tail, which has the capacity to fold into a unique secondary structure called a G-
quadruplex (G4). Evidence for possible G4 formation in vivo came from in vitro 
experiments on telomere structural proteins, such as TEBPα and TEBPβ in ciliates and Rap1 
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in S. cerevisiae which promotes the formation of G4 DNA and on the contrary to the human 
telomeric G-strand binding protein protection of telomeres protein 1 (POT1) promotes the 
unfolding of G4 structures in vitro [Wang et. al., 2011]. The G4 existence in ciliates was 
made possible with the production of G4 antibody raised from ribosome display against 
parallel and anti-parallel telomeric G4T4 structures. In the Stylonychia lemnae only 
antibodies raised against antiparallel G4 structures bind to S. lemnae telomeres, providing 
important indications that antiparallel, and not parallel are present in vivo. Experimental 
controls also showed that the G4 formation is not induced by anti-G4 antibodies. Instead 
analysis from RNAi experiments showed that the formation of G4 depended on TEBPα to 
bind to the telomeric overhang and recruits TEBPβ with its highly charged carboxyl 
terminus. These telomeric G4 structures although are present during most of S. lemnae cell 
cycle, are resolved during replication. Removal of G4 requires phosphorylation TEBPβ and 
its removal from telomeres [Paeschke et. al., 2005; Fang et. al., 1993]. In support to these 
findings, the existence of G4 at the human telomere has been recently reported [Lam et. al., 
2013; Biffi et. al., 2013]. The ability of ssTEL to form G4 could influence the competition 
between Replication protein A (RPA) and protection of telomeres (POT1)/telomere 
protection protein (TPP1) in protecting the telomeric termini. The telomeric termini is 
protected against DNA damage signals through the binding of POT1/TPP1 to single-
stranded telomeric DNA (ssTEL). Association of POT1/TPP1 with shelterin or other 
telomere-associated proteins maybe required to compete against RPA binding since RPA is 
abundantly found in eukaryotes and having similar affinity towards ssTEL. (RPA binding to 
ssDNA, including telomeric overhangs, activates the ataxia telangiectasia and Rad3-related 
checkpoint). The formation of thermodynamically stable G4 could probably be regarded as 
obstacles for recruitment of telomerase and translocation of the DNA replication machinery, 
and their unfolding requires helicase activity or ssDNA binding proteins.  
Several others ssDNA and helicases have also been shown to unwind G4 structures such as 
WRN, Pif1, FANCJ and BLM. Their mutations result in genomic instability, suggesting a 
role in processing of G4 structures is central for maintaining genome integrity. Moreover, 
the Human Bloom helicase (BLM) from RecQ family helicase is shown to bind with high 
specificity to G4 at the telomere.  
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1.5.4 G-quadruplex in Replication 
DNA replication allows the faithful duplication of the whole genome before each cell 
division. During DNA replication, the double-stranded DNA double helix is separated in 
which one serves as the template for leading strand synthesis and the other for lagging strand 
synthesis. Due to the antiparallel nature of the DNA molecule, DNA polymerases moves 
from 3’ → 5’ direction on the template strand thus synthesizing new chains continous chain 
in the 5’ → 3’ direction. The lagging strand is however discontinuous as the new strand is 
formed in a direction opposite that of the movement of the replication fork, creating short 
fragments of transient single stranded DNA called the Okazaki fragments.  This transient 
event provides a favorable condition for G4 to form, although the Okazaki fragment is 
protected by replication protein A (RPA). The protection is overcome as RPA since has low 
affinity for DNA that is made of guanines and adenines. The entire replication fork is stalled 
when DNA polymerase suddenly faces a four-stranded obstacle in the template which it 
cannot disentangle under normal conditions [Woodford et. al., 1994]. These predictions 
were corroborated by Biffi et. al. (2013) that demonstrated the accumulation of G-
quadruplexes during the S-phase of the cell cycle, the phase which replication occurs. 
 
Figure 9. Replication in the leading and lagging strands [Molecular Biology of the Cell. 4th edition]. 
 
G-quadruplexes formed during replication or pre-formed before have to be resolved 
for the completion of DNA replication. Hence, helicases are likely to be recruited to unwind 
the G4 structures. Helicases such as the RecQ, Werner syndrome (WRN), Fanconi Anemia 
Group J (FANCJ), Bloom’s syndrome (BLM) and PIF1 are some of the examples known to 
unwind G4 structures in vitro. Lost unwinding function often is associated to detrimental 
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effects on genome homeostasis which lead to genome instability. The association of these 
helicases with genome instability has renewed interests that G4 unwinding could be 
involved to suppress premature ageing and cancer. The FANCJ-depleted human cells are 
sensitive to a G4- specific binding compound and show elevated DNA damage and 
apoptosis upon exposure to the drug [Wu et. al., 2008]. Moreover, FANCJ-deficient cells 
accumulate deletions at genomic sequences with a G4 DNA signature [London et. al., 2008], 
suggesting that FANCJ prevents replication-associated DNA damage by removing G4 
structures. Similarly, a distantly related FANCJ helicase, the Caenorhabditis  elegans DOG-
1 helicase, which its mutation causes genome-wide deletions in the G-rich regions 
containing G4 motifs. It is also been postulated that the human RTEL helicase, together with 
BLM, protect telomere from instability. 
Another class of helicase, Pif1, acts at G4 motifs.  Pif1 is a multi-functional DNA helicase 
that binds >1,000 sites in the genome of mitotic cells, of which ~10% overlap G4 motifs, 
representing approximately ~25% of the G4 motifs of the yeast.  Absence of Pif1 slows 
DNA replication and DSBs to occur at G4 motifs. The yeast Pif1 is an efficient G4 unwinder 
of parallel intramolecular G4 and is involved in the maintenance of nuclear and 
mitochondrial genome stability [Boule et. al., 2006]. In a study, Pif1 was shown to prevent 
genomic instability of a G4 forming human minisatellite sequence inserted into the S. 
cerevisiae nuclear genome [Ribeyre et. al., 2009] and involved in the coordination of 
checkpoint activation following telomere uncapping [Dewar et. al., 2010. The Dna2 
helicase-nuclease implicated in Okazaki fragment processing, has dual functions to unwind 
G-quadruplex substrates with a 5’ ssDNA tail and as well as degrading G-quadruplexes in 
the presence of the single-stranded DNA binding protein RPA [Masuda-Sasa et. al., 2008]. 
Lam et. al. (2014) in a study using chromatin immunoprecipitation followed by sequencing 
(ChIP-seq) reported that pyridostatin that preferentially bind to G4 motifs, causes replication 
and transcription-dependent damage, seen by its high γH2Ax content. These γH2Ax foci 
were seen overlapped with GFP–PIF1 foci in the pyridostatin-treated human cells. The 
current hypothesis is that G4 formation or stabilization blocks transcription and/or 
replication, resulting in DNA damage. 
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Figure 10. Diagrammatic depiction on the role of Pif1 helicase in resolving G-quadruplex during 
replication. a) A normal replication machinery without G4 formed. b) G-quadruplex formed in the 
lagging posed a blockage to an advancing replication machinery. Pif1 helicase resolves G4 to 
remove the block, enabling DNA polymerase-δ transcribing the Okazaki fragments. [Mirkin, 2013]. 
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1.5.5  G-quadruplex in transcription 
The high concentration and non-random distribution of G4 motifs particularly near 
promoter regions suggests a potential function of G4 structures in gene regulation. At least 
one or more G4 motifs are found within 1,000 nt upstream of the TSS of 50% of human 
genes. Intriguingly, bioinformatics show that the promoters of human oncogenes and 
regulatory genes (for example, transcription factors) are more likely than the average gene to 
contain G4 motifs, whereas G4 motifs are under-represented in the promoters of 
housekeeping and tumour suppressor genes. A similar enrichment of G4 motifs in promoter 
regions is found in other organisms, including yeast, plants and bacteria. Additionally, in 
humans, G4 motifs are less often found in the template strand than in the non-template 
strand. Those that are on the template strand tend to cluster at the 5ʹ end of the 5ʹUTR. 
1.5.6  Possible consequences of G4 structures formed during transcription.  
DNA topology as reviewed in Chapter 1.1 pointed out some of its important roles in 
transcriptions, both positive and negative.  This includes non B-DNA such as G4. G4 
structures have been postulated to form during transcription as a result from supercoiling-
induced stress during transcription. First and foremost, their positions near the promoter 
regions especially on which strand they are formed. They are said to inhibit transcription 
when these structures are found on the template strand but enhancing transcription when G4 
structures are formed on the non-template strands.  
The proteins bound to the G4 structures could also affect transcription. The G4 structures 
formed in the mammalian MYC locus is one of the well-studied genes. G4 structures formed 
in G-rich region of NHE III1 in the c-MYC have been reported to regulate transcription 
[Siddiqui-Jain et. al., 2002]. MYC is a transcription factor whose expression is associated 
with cell proliferation. Increased levels of MYC expression are observed in 80% of human 
cancer cells, and this increase promotes tumorigenesis. Nuclease hypersensitive element 
(NHE III1) is a highly conserved sequence located 142–115 bp upstream from the P1 
promoter has been shown to be required for 80–95% of c-MYC transcription, controls >80% 
of the MYC transcription. NHE III1 highly sensitive to DNase I and S1 nucleases, hence, a 
feature to enable it to equilibrate between transcriptionally active forms (duplex and single-
30 
 
stranded DNA) and a silenced four-stranded structure under physiological conditions in 
vitro. Footprinting studies and luciferase reporter assays comparing the expression of a gene 
with a wild-type NHE III1 versus one with a mutated NHE III 1 that cannot form a G4 
structure demonstrate that the G4 motif in NHE III represses transcription. In another study, 
TMPyP4, a compound that binds to and stabilizes G4 structures in the NHE III1 reduced 
MYC transcription in lymphoma cell lines and showed antitumour activity in mice. TMPyP4 
catalyzes the oxidation of DNA upon exposure to light, which results in DNA strand 
breakage in proximity to the binding sites.  
In a study by Gonzales et. al.(2009), the G4 structures which are formed at the NHE III1 act 
as signaling elements, through the binding of nucleolin to G4 structures as a c-myc G-
quadruplex-binding protein. Nucleolin is a nucleolar phosphoprotein that is highly expressed 
in proliferating cells, known mainly for its role in ribosome biogenesis [Ginisty et. al., 
1998]; however, nucleolin also functions in chromatin remodeling [Angelov et. al., 2006], 
transcription [Yang et. al., 1994; Grinstein et. al., 2007], G-quadruplex binding [Dempsey 
et. al., 1999], and apoptosis. Nucleolin is a modular protein that can be structurally divided 
into three different domains as follows: the N-terminal, the central domain that includes the 
four RBDs, and the C-terminal domain [Ginisty et. al., 1998]. It has been show that 
nucleolin binds with higher affinity to the c-myc G-quadruplex structure over its consensus 
NRE-RNA substrate. In addition, the ability of the c-myc G-quadruplex to displace the 
NRE-RNA from binding to nucleolin suggests that RBD1 and RBD2 preferentially bind to 
the c-myc G-quadruplex structure [González et. al., 2009]. Other hypothesis on nucleolin-G4 
binding associated transcription regulation is that nucleolin-mediated G4 formation in 
NHE III 1 inhibits MYC transcription by masking binding sites for MYC transcriptional 
activators, such as the transcription factor SP1 [Bochman et. al., 2012] and cellular nucleic 
acid-binding protein (CNBP) [Borgognone et. al., 2010]. 
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1.5.7  Regulation through proteins binding to G4 structures.  
Transcription may also be altered by G4 binding proteins that affect the formation and 
unfolding of G4 structures. The myosin D (MyoD) family proteins are transcription factors 
that bind to E-boxes in the promoters of several muscle-specific genes to regulate muscle 
development. In vitro, MyoD homodimers bind preferentially to G4 structures from the 
promoter sequences of muscle specific genes. It is hypothesized that MyoD homodimers 
preferentially bind to the G4 structure when G4 structures form in the promoters of E-box 
driven gene. Consequently, MyoD–MyoE heterodimers, which cannot bind G4 structures, 
bind to the E-box instead and enhance gene transcription. Genome-wide studies analysing 
the effects of drugs that stabilize and/or induce G4 formation have shown that the expression 
levels of many genes are affected by treating cells with G4 ligands. In support to this, the 
effects of mutations in helicases known to unwind G4 DNA on transcription genome wide 
were studied. For instance, in human fibroblasts deficient for the WRN or BLM RecQ 
helicases, the transcription of genes that are predicted to form intramolecular G4 structures 
is significantly upregulated which correlates with the G4 motifs but not G-richness. The 
genes associated with G4 motifs account for 20–30% of all transcripts that are upregulated 
in WRN and BML mutant cells. Despite these, the high stability and thermodynamic of G4 
and the fact that G4 structures are slow formed that is resolved with the existence of 
chaperones (for example, TEBPβ and Rap1) that promote the formation of G4 DNA to 
overcome this slow formation [Bochman et. al., 2012]. Thermodynamic and kinetic 
measurement of G4 structure formation indicates that G4 structures can form cooperatively 
and it is possible that other intramolecular G4 structures form as readily. Unwinding of G4 
structures in a timely manner can also no longer be considered a problem given the 
discovery of helicases that bind and unwind G4 motifs with high efficiency. 
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Figure 11. Putative functional roles of G-quadruplex during transcription [Bochman et. al., 2012]. 
 
1.5.8  G-quadruplex binders 
Numerous studies on synthetic molecules that interact with G-quadruplexes have 
helped demonstrate the existence and elucidate putative biological roles of these nucleic acid 
structures. The G4 stabilizers can be broadly classified into small molecules, non nucleoside 
compounds such as telomestatin, Braco-19, TMPyP4 are predicted to bind within the 
grooves or DNA intercalators such as porphyrins and cisplastin are compounds which tend 
to have large flat aromatic surfaces and are cationically charged to allow for π – stacking 
interactions. These platinum-bridged compounds are reported to inhibit telomerase activity 
in vitro, with distinct covalent linkage that could lock G4 irreversibly. Although reported to 
target the G4 structures at telomeres, some these compounds are also shown to bind to non-
telomeric G-rich regions of the DNA promoters, preventing the access of transcription 
factors.   
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Despite the numerous G4 binders being found, only 3 of them are reviewed here as they 
have been used in this work. Pyridostatin has been the most recent to be studied for its 
ability to bind G4 structures and visualized in vitro.  Pyridostatin, described by Müller et.al., 
(2012), is a highly selective G-quadruplex-binding small molecule which alters transcription 
and replication of particular human genomic loci containing high G-quadruplex clustering 
within the coding region, which encompasses telomeres57 and selected genes such as the 
proto-oncogene SRC. Downregulation of oncogenes has been shown in SRC and c-MYB in 
glioma cells. In the telomeres, Pyridostatin induces telomere dysfunction by competing for 
binding with telomere associated proteins such as human POT [Rodrigues et. al., 2008]. Its 
biotinylated Py analogue is able to mediate the selective pull-down of telomeric fragments 
from genomic DNA by means of affinity matrix isolation. Pyridostatin has been shown to 
demonstrated high selectivity towards G-quadruplex nucleic acids, regardless of sequence 
variability and structure polymorphism, compared to double-stranded DNA [Müller et. al., 
2010].    
Unlike other G4 binders, Pyridostatin is designed with the capability to adopt a flat but 
flexible conformation, facilitated by an internal hydrogen bonding network, prone to adapt 
to the dynamic and polymorphic nature of diverse G-quadruplex structures. It has an optimal 
electronic density of the aromatic surface to enable π–π interactions with the G-tetrad tuned 
by substituents (for instance alkoxy or halogens capable of altering the electron density) and 
the presence of free nitrogen lone pairs able to coordinate with a molecule of water or 
alternatively to sequester a monovalent potassium cation in the centre, thus locking the flat 
surface of the molecule and facilitating the interaction with G-quartets (Figure 12). 
34 
 
 
Figure 12. Chemical structures of G-quadruplex binders. a) Pyridostatin; b) Diimidazole [1,2-a:1,2-
c]pyrimidine derivatives; Structure (1), termed as FG, has guanylhydrazone groups in their side 
chains; Structure (2), termed as FA, which lack charged side-chains, is devoid of quadruplex- or 
duplex- binding activity. c) BRACO-19 ((9-[4-(N,N-dimethylamino)phenylamino]-3,6-bis(3-
pyrrolodino-propionamido) acridine) [Müller et. al., 2012; Sparapani, 2005; Burger et. al., 2005]. 
 
Other examples of G-quadruplex binders of alkylamidoacridines-based telomere-targeting 
agents, Braco-19 (Figure 12c) and diimidazole [1,2-a:1,2-c]pyrimidine derivatives (Figure 
12b). Braco-19 interacts with G4 structures via π-π stacking. Positively charged side chains 
of the inhibitor interact with the negatively charged phosphate DNA backbone and thereby 
stabilize the G-quadruplex–inhibitor complex. It was reported that a treatment with 
BRACO19 not only resulted in telomerase inhibition but also in general telomere 
dysfunction that led to atypical mitosis and consequently to apoptosis (Burger, 2005). The 
diimidazole [1,2-a:1,2-c]pyrimidine derivative, bis-guanylhydrazone derivative of 
diimidazo[1,2- a:1,2- c]-pyrimidine is a potent in vitro inhibitor of telomerase.  Molecular 
modeling suggests that the guanylhydrazone groups play an active role in quadruplex  
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binding [Sparapani et. al., 2005; Andreani et. al., 2004]. Biophysical assays by FRET 
melting assays showed outstandingly high ΔTm with the human telomeric quadruplex, 
quadruplexes c-kit1 and c-kit2 from the promoter region of the c-kit gene. Moreover, the 
compound was previously examined for their anti-proliferative activity in the NCI 60 cancer 
cell line panel with significant activity in ovarian line IGROV1 [Sparapani et. al., 2005]. 
 
1.6  R-loops  
R-loops are three stranded structure which form when RNA hybridizes to a 
complementary DNA strand of a DNA duplex, leaving the opposite DNA strand single-
stranded. The R-loop structure has been first characterized in vitro over 35 years ago. As 
observed under the electron microscope, these thermodynamically stable R-loop structures 
appeared similar to the D-loop structures reported by Robberson et al. during mtDNA 
replication [Thomas et. al., 1976].  
The role of R-loops was firstly established in bacteria by Tomizawa et al in the 1980s. 
During the replication of ColE1 family of plasmids, where DNA synthesis was found to be 
initiated by an R-loop with a cleaved 3'-OH end [Itoh et. al., 1980; Selzer et. al., 1982]. 
Kogoma et. al. (1997) reported that the RNase H1in E.coli hydrolyses R-loops. The enzyme 
that targets RNA exclusively in RNA-DNA hybrids belong to the RNase H family. There 
are two types of RNase H, H1 and H2, characterized by their biochemical properties and 
substrate preference, are potentially capable of removing RNA-DNA hybrids. Rnase H1 
being the most conserved type is present in retroviruses, bacteria and humans. Its specificity 
in target recognition is due to a ~50 aa N-terminal RNA/DNA hybrid-binding domain that is 
connected to the C-terminal catalytic domain (~150 aa) by a flexible linker, within the 
residues D145, E186, D210, and D274 form the active site. Any mutation of at least one of 
these residues inhibits enzymatic activity [Nowotny et. al., 2007]. 
As a consequence of transcription process, R-loops formation resulted in hybridization 
between nascent RNA transcript and DNA template, called ‘co-transcriptional R-loop’ 
formation [Drolet et. al., 1995]. These R-loops are reported to mediate the establishment of 
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replication forks for chromosomal DNA replication in a phenomenon described as 
constitutive stable DNA replication (cSDR) in E.coli cells deficient either for RNase HI or 
RecG but not both as it causes lethality. 
The R-loops formation is well-characterized in the mammalian mitochondrial origin of 
replication and immunoglobulin (Ig) class switch regions of activated B lymphocytes [Yu et. 
al., 2003; Lee et. al., 1996]. Their formation depends on a number of features, such as G•C 
content, DNA supercoiling, and DNA cleavage. In bacteria, the Ig class-switch S regions 
consist of G clusters on the non-transcribed strand and are followed by regions with high G 
density. G-clustering or GC skew, a similar term coined for G-clustering on the non-
transcribed strand are important for R-loop initiation and G-density involves in the 
stabilization and elongation of the RNA:DNA hybrid [Ginno et. al.,2012; Vertino et. al., 
2012; Roy et. al., 2009].  
The key element for R-loop formation in vivo being the negative superhelicity that negative 
supercoiling increases the length of the RNA:DNA hybrid and reduces the G dependency 
[Roy et. al., 2009]. Both features facilitate the opening of the bubble of DNA duplex 
[Aguilera et. al., 2012] and this can be seen in Top1-deficient mutants of E. coli that 
inability of Top1 to relax the negative superhelicity of DNA warrants lethality.  
A R-loop model consisted of three distinct parts: R-loop initiation zone (RIZ), linker and R-
loop elongation zone (REZ) [Roy et. al., 2009]. G-clusters in RIZ are extremely important 
for the initiation of R-loop formation while the linker between RIZ and REZ consisted of 
any nucleotide composition. The final part of R-loop, REZ sequence, is required to be of 
high G density but does not necessarily have to be a G-cluster. This model can be applied for 
in vivo R-loop detection and facilitate the search of potential R-loop forming sequences 
(RLFS) in the genome [Roy et. al., 2008]. Wongsurawat et. al. using predictive algorithm 
proposed a model based on Roy and Michael Lieber’s model. RLFS can be partitioned into 
three segments: RIZ; linker and REZ or  
RLFS=RIZ+linker+REZ 
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RIZ. The DNA regions of initiation of R-loops are considered as clusters of a few Gs (3–4 
nt) in the region. Segment sequence initiates and terminates with G-cluster that contains at 
least three contiguous.  
Linker. The DNA sequence region between RIZ and REZ regions is called linker. The 
nucleotides in this region are not specified and also the length is variable from 0 to 50 nt. 
REZ. Downstream of RIZ and Linker, REZ can support the extension of R-loop with a high 
G density. REZ has to be G-rich but does not require G-cluster like RIZ. At least 40% of G 
is required for R-loop formation. In Wongsurawat’s model, nucleotide number of REZ can 
vary from 100 to 2000 nt.  
 
Figure 13. a) Identification of in vitro R-loop using electron microscopy (Thomas et al 1976). b) 
Transcription with and without R-loop forming structure. R-loop initiation zone (RIZ) and R-loop 
elongation zone (REZ) are highlighted in yellow blue, respectively [Wongsurawat et. al., 2011]. 
 
Two mechanisms are proposed for the formation of R-loop at a transcribed sequence [Roy 
et. al., , 2010; 2009; 2008). In the ‘thread-back’ model, the nascent transcript is ejected from 
the RNA polymerase at the site of transcription but threads back to bind to the DNA 
template strand to form the hybrid, as in the case of linear templates of the murine 
immunoglobin Sϒ3 class switch recombination region [Roy et. al., 2008]. In the ‘extended 
hybrid’ model, the nascent transcript fails to denature from the template in the transcription 
bubble, due to the high thermodynamic stability between RNA–DNA hybrids. This 
mechanism is involved during a transcriptionally induced R-loop in immunoglobin sequence 
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on supercoiled templates but also at expanded trinucleotide repeat tracts [Reddy et. al., 
2011; Duquette, 2004]. 
 
Figure 14.  Schematic representation of the two possible mechanisms for R-loop formation. The 
“thread-back” model on the left and the “extended-hybrid model” on the right. The nascent transcript 
is depicted in light blue, free DNA template strand in red, RNAse A in dark blue and the RNA 
polymerase as an light blue oval [Reddy et. al., 2011]. 
 
R-loops sequences in length from 150 to 650 bp in Ig switch region, from 110 to 1280 bp in 
Bcl6 and from 120 to 770 bp in RhoH [Wongsurawat et. al., 2011]. Their stability, 
depending on the oligomeric length, the content of deoxypyrimidines/deoxypurines, and the 
A•T/U proportion, is typically higher than DNA:DNA associations and the relative stability 
of these hybrids [Shaw et. al., 2008]. Hence, their formation can be a costly energy-
consuming process. NMR and X-ray diffraction studies indicate that RNA:DNA hybrids 
adopt a conformation that is intermediate between those of dsDNA (B form) and dsRNA (A 
form) [Shaw et. al., 2008]. This special structure might be important as a recognition 
element, since hybrids have to be distinguished in vivo from normal dsDNA for removal. 
[Aguilera et. al., 2012]. 
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1.6.1  Hypernegative Supercoiling and Cotranscriptional R-loops  
One consequence of TopI depletion in cells is the accumulation of hypernegatively 
supercoiled DNA behind the transcribing RNAP. Negative supercoiling behind the 
transcription bubble can lead to opening of the DNA. When this happens, the nascent RNA 
may hybridize to the transcribed strand, creating RNA R-loops. Negative supercoiling is 
linked to the formation of R-loops in E. coli. RNase H abolishes transcription-dependent 
supercoil accumulation in vitro [Drolet et. al., 1994]. In addition, R-loops have a negative 
effect on cell metabolism and growth as suggested by the lethality of topA rnhA mutants 
[Drolet et. al., 1995]. Finally, E. coli topA-null mutants fail to accumulate full mRNAs and 
rRNAs, a phenotype suppressed by RNase H overexpression and consistent with a negative 
effect of R-loops in transcription efficiency. A connection between hypernegative 
supercoiled DNA and R-loops in vivo also exists in S. cerevisiae. RNA:DNA hybrids form 
in wild-type yeast cells at the rDNA region and are significantly increased in top1Δ top2Δ 
strains and further enhanced in the absence of RNase H1. Further analyses have shown that 
truncated fragments of pre-rRNA accumulate in top1Δ mutants [El Hage et. al., 2010]. 
A link between R-loops and supercoiling also seems to occur in mRNA transcription as 
shown in human cells, in which Top1-depletion causes replication impairment at regions 
rich in protein-encoding genes. This impairment is suppressed by RNase. The observation 
that a nick in the DNA potentiates RNA:DNA hybrid formation in vitro strongly suggests 
that a free end either in the DNA or RNA strand would facilitate the intertwining of RNA 
with DNA. It may be possible thereby that cleavage of the nascent RNA molecule facilitates 
R-loop formation in negatively supercoiled DNA upstream of the elongating RNAP [Roy et. 
al., 2010].  
All these notions make reasonable that the R-loop formation in vivo is a dynamic process 
involving protein–DNA–RNA interactions. Top1 may prevent an accumulation of negative 
supercoiling downstream of transcription block and can prevent R-loop formation [Pommier 
et. al., 2006].  
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Figure 15. During transcription the nascent pre-mRNA is fully packed by the hnRNPs. 
Hypernegative supercoiling and mRNP biogenesis defect contribute to aberrant formation of R loops 
formed by the nascent RNA. [Aguilera et. al., 2012].  
 
1.6.2  R-loops formation as a natural event 
1.6.2.1  Replication  
R-loops are obligatory intermediates in specific cellular processes. They are most studied in 
the replication of bacteriophage T4, E. coli ColE1 plasmid and mitochondrial DNA.  
The bacteriophage T4 initiates DNA replication by two mechanisms, one of which, the 
recombination-dependent replication (RDR) forms R-loop. Immediately after bacterial 
infection, replication is initiated at several origins including oriG, which harbors a promoter. 
Transcripts initiated at such promoter form persistent R-loops that are likely processed by 
T4 RNase H to generate the free 3’-end required for lagging-strand DNA synthesis. In 
bubble-migration synthesis model, lagging strand synthesis does not occur, and the newly 
synthesized single strand is extruded from the back of the D-loop as new DNA is 
synthesized at the front of the D-loop [Kreuzer et. al., 2010].  
 
In E. coli, initiation of replication ColE1 is RNAP-dependent RNA synthesis. ColE1 
initiation of replication relies on the formation of an RNAP-driven 550 bp sequence, termed 
RNAII, which forms a stable RNA:DNA hybrid with the leading-strand DNA template. This 
RNAII is processed by RNase H1 to generate a 3’ end and is extended by DNA Pol I [Itoh 
41 
 
et. al., 1980]. Interestingly, E. coli RNase H1 mutants (rnhA) replicate the chromosome in 
the absence of dnaA and other canonical replication initiation factors normally required at 
oriC [Kogoma et. al., 1997]. It is believed that persistent R-loops in rnhA mutants can 
initiate replication independent of oriC, mimicking initiation of ColE1 [Lee et. al., 1996].  
 
Mitochondrial DNA (mtDNA) replication is similar to ColE1 replication mechanism, with 
DNA synthesis being primed by an RNA molecule produced by the mitochondrial RNAP 
[Xu et. al., 1996]. mtDNA is a double-stranded circular molecule that encodes essential 
subunits of the mitochondrial respiratory chain, as well as the tRNAs and rRNAs required 
for their synthesis. mtDNA consists of two major promoters: the light strand promoter (LSP) 
and the heavy strand promoter (HSP). Transcription by RNA polymerase (POLRMT), starts 
at both LSP and HSP and is polycistronic, producing near genome-length transcripts that are 
later processed to give rise to the individual mRNA molecules [Falkenberg et. al., 2007]. In 
mitochondria, transcription and DNA replication are closely linked, since POLRMT is 
responsible for the synthesis of a RNA primer required for initiation of DNA synthesis by 
the mtDNA polymeraseϒ (POLϒ) from the mitochondrial origins of replication, OriH and 
OriL [Fuste et. al., 2010]. In addition to POLϒ, the mitochondrial replication machinery also 
consists of a replicative helicase, TWINKLE, and a single-stranded DNA binding protein, 
mtSSB. In combination, these three factors form replication machinery that can synthetize 
ssDNA molecules longer than 16.5 kb, the size of the human mtDNA genome [Falkenberg 
et. al., 2007]. In mammals the RNA molecule is transcribed from the light-strand promoter 
(LSP), using this strand as a template, and terminates at OriH. Once processed by RNase H 
the RNA molecule is used as primer by DNA Polϒ and the light chain starts being 
replicated. The heavy chain is displaced, forming a loop (called “D-loop”) and only in a 
second moment undergoes itself replication. Sequence comparison in vertebrates reveals 
three conserved sequence blocks (termed CSB I, CSB II, and CSB III), downstream of LSP. 
The RNA-DNA hybrid, is stable and persistent and its formation is dependent on the CSBII 
element, in yeast and in human [Wanrooij et. al., 2012]. On the contrary, human mtRNA 
sequence upstream of the hybrid region is also important for efficient RNA-DNA hybrid 
formation, especially the conserved CSBIII element which is absent from the putative yeast 
mitochondrial origins. However, the exact role of CSBIII, in the form of DNA and RNA, is 
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not known. Its complete removal permits RNA-DNA hybrid formation in a manner similar 
to the natural situation in yeast [Xu et. al., 1996]. The extraordinary stability of the 
mitochondrial R-loop was explained by the discovery of G-quadruplex DNA structure in the 
R-loop forming sequence, by preventing reannealing of the template and non-template DNA 
strands [Wanrooij et. al., 2012; Lee et. al., 1996]. 
  
 
Figure 16. R-loops formation as natural event with a role in Replication. A) Recombination-
dependent replication (RDR) of Bacteriophage T4. Left: semi-conservative RDR model, right: 
bubble-migration synthesis model. New leading strand replication is in solid red and new lagging 
strand replication is in dashed red (Kreuzer et. al.,2010). B) R loops in ColE1-type plasmids 
replication C) R loops in mammalian mitochondrial light DNA strand replication (Aguilera et. al., 
2012). D) Schematic representation of the D-loop regulatory region. The three conserved sequence 
blocks (CSB I, CSB II, and CSB III) are located just downstream of light-strand promoter (LSP).  
The conserved termination-associated sequence (TAS) elements are also represented Falkenberg et. 
al. (2007).  
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1.6.2.2  Recombination  
The Ig class switching in vertebrate B cell plays an essential process for the generation of 
specific and high affinity immunoglobulins.  
Various isotypes of immunoglobulins have different effector functions for optimal immune 
responses to pathogens. Prior to pathogen exposure, a highly diverse repertoire of low-
affinity IgM antibodies are generated through V(D)J recombination. When B cells encounter 
antigens, more effective isotypes of immunoglobulins are produced through two additional 
DNA modifying mechanisms: somatic hypermutation (SHM) and class switch 
recombination (CSR) [Yu et. al., 2003; Dunnick et. al., 1993]. CSR is responsible for 
changing the heavy chain isotype from IgM to IgA, IgE or IgG. 
CSR occurs only at the repetitive switch (S) regions, located downstream of a promoter. 
These sequences are GC-rich, located particularly on the non-template strand DNA. In 
addition, they consist of 25–80 bp repeat units stretching a total of 1–10 kb in length 
[Dunnick et. al., 1993]. All switch regions have promoters that respond to B cell activation 
and cytokines. Transcription is required for CSR. Activation-induced cytidine deaminase 
(AID) is the key enzyme in both CSR and SHM that deaminates cytidines of the single 
stranded DNA. The action of AID at the displaced G-rich ssDNA is the first step for the 
generation of the double strand break responsible for CSR. The DNA in switch regions 
becomes single-stranded during SHM and CSR is by transcription. It is however, not all AID 
is seen to be recruited deaminates cytidines in ssDNA [Roy et. al., 2008]. Therefore, both 
CSR and SHM possess special mechanisms to recruit AID to switch regions and the VDJ 
region, respectively. R-loops are known to form at switch regions but their role was unclear 
until it was shown that these structures could accentuate AID targeting in murine primary B 
cells. The R-loops of few hundred base pairs provide sufficient numbers of single-stranded 
cytidines for AID to act on with greater efficiency than would otherwise occur [Roy et. al., 
2008].  
An example of R-loops, TERRA, form naturally by the telomeric transcripts. TERRA 
involves RNA:DNA hybrids is implicated in telomerase activity inhibition [Luke et. al., 
2008]. There are also noncoding RNAs (ncRNAs) reported to form R-loops, of unknown 
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physiologically meaning, but has a role in mediating RNAi-directed heterochromatin 
formation in fission yeast [Aguillera et. al., 2012].  
 
Figure 17. R loops in Ig class-switch recombination. Gs are indicated as thin vertical lines (Aguillera 
et. al., 2002). 
 
1.6.2.3  Gene expression 
R-loop structures affect gene expression, whether by blocking gene elongation or by 
repressing gene expression itself. In E.coli, R-loop formation in the Top1 mutants leads to 
growth defects, impaired transcription elongation on the rDNA and extensive RNA 
degradation by RNase H [Drolet et. al., 2005].  
Hage and coworkers reported that pre-rRNA transcription is affected by the absence of Top1 
in yeast and that these pre-rRNA fragments not only accumulated in the absence of Top1 but 
also hybridized to the template strand, forming an R-loop. rRNA synthesis was also reduced 
in these strains, supporting the conclusion from in vitro data that stable R-loops block 
transcription elongation [Aguilera et. al., 2012]. These truncated pre-rRNA fragments were 
stabilized in top1Δ strains defective in TRAMP (trf4Δ) or the exosome (rrp6Δ), indicating 
that these complexes degrade the pre-rRNA fragments released by RNase H cleavage. 
Depletion of Top1 increases both the frequency of pileups and the numbers of contiguous 
polymerases, presumably reflecting increased duration of stalling of the leading polymerase. 
In this strand Top2 is supposed to resolve positive and negative supercoiling. Both activities 
should lead to the release of transcriptional blocks, but Top2 is not predicted to resolve 
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strand separation induced by negative torsion. In strains lacking both Top1 and RNase H 
activity, pileup frequency increased further. The presence of persistent R-loops might slow 
down local rotation of the rDNA, reducing the speed of elongation of Pol I in the same 
pileup, which would increase the residency times of pileups and impede their resolution. 
[Hage et. al., 2010]. 
 
 Figure 18. R-loops’ role in blocking pre-rRNA transcription. a) Polymerase movement during 
transcription forces the rDNA to rotate, building up positive and negative torsion, resolved by Top1. 
b) In strains lacking Top1, more torsion is accumulated and R-loops occur more frequently, leading 
to an increase in pileup formation. RNase H1 and H2 cleave the RNA–DNA hybrids, releasing 
truncated pre-rRNA fragments that are targeted and degraded by the TRAMP and exosome 
complexes. c) In the absence of both Top1 and RNase H1 and H2, persistent R-loops block rotation 
of the rDNA and cause severe polymerase arrests and pileups [Hage et. al., 2010]. 
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R-loop formation in bacteria is reported with termination failures. The absence of functional 
Rho-dependent termination has been inferred to lead to R-loop accumulation, as these 
mutants require RNase H activity for survival. 
Different studies suggest that transcription termination in RNAPII-driven genes may 
represent an additional and relevant case in which R-loops could form naturally in 
eukaryotic cells. Transcription pause sites located downstream of the poly(A) signal 
facilitates termination. Specific nucleases and helicases participate in the degradation of the 
downstream-cleaved RNA as key factors for template release, including yeast Rat1 
exonuclease. In yeast the Sen1 RNA:DNA helicase cooperates with Rat1 to promote 
efficient transcription termination. Loss of Sen1 results in RNA:DNA hybrid accumulation, 
suggesting that R-loops may form as natural transcription intermediates that are removed by 
Sen1 [Mischo et. al., 2011].  
Senataxin (SETX), the human ortholog of Sen1, is required to avoid transcript read through. 
This is due to the incapacity of SETX-depleted cells to properly terminate transcription and 
correlates with RNA:DNA hybrid accumulation downstream of the poly(A) signal. It has 
been proposed that R-loops may be critical for RNAPII to pause downstream of the poly(A) 
site and that Senataxin may unwind the RNA:DNA hybrids. Therefore, termination could 
use short RNA:DNA hybrids to potentiate pause sites and/or as a step required for 
exonuclease degradation of the nascent RNA necessary for template release [Skourti-
Stathaki et. al., 2011]. G-rich sequences immediately downstream of the poly(A) signal are 
common in mammalian genes and potential G4-forming sequences are enriched at the 3’-
UTR regions of genes. Given the potential of G-rich sequences to stabilize R-loops, it might 
be possible that R-loops are intrinsic elements of termination pause sites. [Belotserkovskii 
et. al., 2010].  
Interestingly, approximately 45% of all human genes exhibited GC skew at their core 
promoter region, the vast majority of which (95%) co-occur with promoter CpG islands 
[Marinello et. al.,  2013; Ginno et. al., 2012; Vertino et. al., 2012]. R-loops accumulate 
naturally at these regions, immediately downstream of the CpG-non-methylated promoters. 
It has been proposed that the displaced ssDNA in the R-loop acts as a signal to recruit either 
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the protective H3K4 trimethyl mark or the DNA demethylases complex [Ginno et. al., 2012; 
Vertino et. al., 2012]. Moreover, ssDNA in the R-loop structure is also able to recruit the 
AID enzyme, which is capable of editing nucleic acid through deamination of cytosines to 
uracils. They are most often act in immunoglobulins production and epigenetic 
reprogramming in mammals. They are in active state in primordial germ cells (PGCs) and in 
early embryos where demethylation occurs [Bhutani et. al., 2010; Popp et. al., 2010]. Hence, 
indicating that R-loop structure may be a potential target of AID-mediated epigenetic 
reprogramming [Wongsurawat et. al., 2012].  
R-loops regulate gene expression in an epigenetic manner. Topotecan-induced R-loop at 
Snord116 locus inhibits transcriptional elongation through Ube3a-antisense and promotes 
allele-specific chromatin decondensation [Powell et. al., 2013]. Snord116 is a neuron-
specific noncoding RNA that maps on the Prader–Willi syndrome (PWS)/Angelman 
syndrome (AS) locus, which is regulated by an imprinting control region that is maternally 
methylated and silenced. Epigenetic dysregulation of this locus leads to PWS or AS. The 
PWS imprinting control region is the promoter for a one megabase paternal transcript 
encoding, besides Snord116, the ubiquitous protein-coding Snrpn gene, other neuron-
specific noncoding RNAs, and the antisense transcript to Ascausing ubiquitin ligase 
encoding Ube3a (Ube3a-ATS). All these results provide a deeper understanding of the 
relationship between epigenetic regulation, chromatin dynamics, transcription and R-loop 
formation [Powell et. al., 2013]. 
 
Figure 19. Persistent RNA:DNA hybrid influences DNMT activity [Vertino et. al., 2012] 
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1.6.2.4  Source of genome instability  
The computational analysis of human genomes has identified possible DNA hotspots 
for the formation of R-loops which are widespread throughout the human genome 
particularly located in genes involved in several diseases. In fact, it is well known that co-
transcriptional R-loops are linked to different forms of genome instability including 
mutations, recombination, and chromosome rearrangements as well as chromosome loss. 
Evidence for R-loops as a source of genome instability is provided by the yeast THO and 
THSC/TREX-2 R-loop-forming mutants which show a transcription-associated hyper-
recombination phenotype and elevated chromosome and plasmid loss [Wongsurawat et. al., 
2012]. R-loops can form in fragile sites in vivo. Common fragile sites (CFSs) are caused by 
collisions between the replication and transcription machineries and such CFSs are linked to 
the formation of RNA:DNA hybrids [Reddy et. al., 2011; Lin et. al., 2010]. 
In S. cerevisiae mutations in genes involved in transcription and mRNA processing/export 
can cause a significant increase in YAC minichromosome loss. This chromosome instability 
(CIN) is linked to mRNA biogenesis factors, in particular mRNA cleavage and 
polyadenylation factors. Cells depleted of such factors form RNA:DNA hybrids, and the 
CIN phenotype is suppressed by RNase H [Stirling et. al., 2012].  
The single-stranded DNA (ssDNA), a by-product from R-loops formation is prone for the 
mutagenic action of specific DNA-modifying enzymes such as AID. The ssDNA displaced 
by the RNA:DNA hybrid may be critical for such mutagenicity, since ssDNA is more 
susceptible to mutagenic DNA damage than dsDNA [Aguilera et. al., 2012].  
R-loops are also involved in the generation of hyper-recombination: translocations occurring 
between S regions and c-myc that are responsible for Burkytt’s lymphoma are AID-
dependent and occur at G-cluster-rich regions prone to form R-loops. Proto-oncogenes 
involved in translocations such as BCL6, RhoH, PIM1, or PAX5 also occur in primary B 
lymphocytes at sites of potential G-quadruplex-rich R-loops [Duquette et. al., 2007]. 
Transcription- induced R loops can lead to genomic instability also by the creation of an 
impediment to replication fork progression, which constitutes a general and evolutionarily 
conserved mechanism underlying R-loop-induced genomic instability [Gan et. al., 2011].  
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Recent evidence has linked R-loop formation at several trinucleotide repeat sequences, 
whose genetic instability, expansions, are the cause of numerous diseases. The genetic 
instability of gene-specific trinucleotide repeat sequences is the causative mutation for 
various neurological, neuromuscular as well as many neurodegenerative. Among these 
diseases there are spinocerebellar ataxia type 1 (SCA1), myotonic dystrophy (DM1) and 
fragile X type A (FRAXA). R-loop forming structures can be found in the Fmr1 and Fxn 
genes that are responsible for neurodegenerative disease. It was demonstrated that R-loops 
could co-localize with some classes of trinucleotide repeat tracks that occur in these genes 
[Groh et. al., 2014]. R-loop structures are found when Fmr1 and Fxn genes are transcribed. 
The RNA–DNA hybridization via R-loop mechanism can generate genetic instability that 
may be associated with the expansion of the trinucleotide repeats within the disease related 
genes [Pereira et. al., 2014; Groh et. al.,  2014]. 
 
 
Figure 20. Proposed mechanism for stable RNA: DNA hybrids stimulating repeat instability [Lin et. 
al., 2010]. 
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A genome-wide siRNA screen in human cells to identify genes involved in genome 
stabilization through H2AX phosphorylation (γ-H2AX) (a cellular mark for double-strand 
breaks), identified a number of factors involved. Among these different proteins involved in 
mRNA processing (such as 3’ end polyadenylation factors), the nuclear exosome involved in 
RNA surveillance, heterogeneous nuclear ribonucleoproteins (hnRNPs), splicing factors and  
nuclear pore complex (NPC) components. Overexpression of RNase H in depleted in any of 
these, reduces the γ-H2AX foci [Aguilera et. al., 2012].  
Acting as mutagenic intermediates, R-loops can cause either gene-specific or genome-wide 
instability. For example, mutations in the THO/TREX complex, which is required for proper 
coupling of transcription and mRNA export, cause wide-scale co-transcriptional R-loop 
formation triggering aberrant recombination leading to genome-wide instability [Gonzalez 
et. al.,  2011]. 
Diseases caused by gene-specific expansions of (CAG)·(CTG) repeats including 
Huntington’s disease, myotonic dystrophy type 1 and a series of spinocerebellar ataxias are 
implicated with R-loop formation (Pereira, 2014). Others include fragile X mental 
retardation involving (CGG).(CCG) repeats and Friedreich’s ataxia involving a 
(GAA)·(TTC) repeat [Groh et. al.,  2014]. 
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Chapter 2 
Materials and methods 
 
2.1  Cell lines 
HCT15 and COLO205 were grown in monolayer cultures in RPMI 1640 while HCT116 was 
grown in DMEM. All growth mediums were supplemented with 10% heat-inactivated foetal 
bovine serum and 2 mM glutamine. The cells were maintained by trypsinization and passed 
2-3 times a week and incubated at 37 °C, 5 % CO2. 
2.2  Preparation of drug compounds 
Camptothecin was initially dissolved in 100% DMSO to make up 10 mM stock solutions 
while Pyridostatin and Braco-19 in 5 mM stock solutions. The stock solutions were 
aliquoted in small vials of 30 µl to avoid repeating freeze-thaw.  Stock solutions were 
diluted immediately prior to use. 
2.3  Western blot 
Cell lines HCT116, HCT15 and COLO205 were grown to 90 % of confluency. The medium 
was discarded and washed with PBS at room temperature. The cells were lysed with SDS 
buffer (Tris-HCl  pH 6.8  50 mM; Sucrose 15 %; EDTA 12 mM; SDS 3 %; β- 
mercaptoethanol 10 %, bromophenol blue) and boiled for 20 mins. The protein lysate was 
put into ice and loaded an equal volume into the polyacrylamide gel. 
 
Bis-acrylamide gel 
Resolving (25ml) 
 Bis acrylamide (19:1) 40 %   8 % 
 Tris-HCl pH 8.8                         405 mM     
 SDS 10 %                                        0.1 %  
 Temed                                              0.21 % 
 APS 10 %                                       0.1 % 
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 H2O to volume   
Stacking (10ml) 
 Bis acrylammide (19:1) 40 %    4 % 
 Tris-HCl  pH 6.8              125 mM 
 SDS 10 %                           0.1 % 
 Temed                                        0.1 % 
 APS 10 %                               0.2 %   
 H2O to volume 
The gel was electrophoresed at 20 mA constant for 2 hrs. Upon finishing, the protein was 
transferred to gel at 100V constant for 1 hour and 30 mins. The transfer buffer consisted of 
25 mM Tris, 192 mM Glycine and 20 % methanol (v/v). After transfer, the membrane was 
colored for 5 minutes with Ponceau red. The membrane was washed with PBS for 2 times 
and once with 1 x TBS/Tween 0.1 % to de-colour red. The membrane was then blocked 5 % 
milk /1 x TBS/Tween 0.1% for 1 hr. The membrane was incubated with goat polyclonal IgG 
anti-Top1 (C-15; Santa Cruz Biotechnology) in dilution 1:200 for 2 hours at room 
temperature and anti β-actin  (Santa Cruz Biotechnology) dilution 1:200. Then, membranes 
were washed in TBS 1 x- Tween 0.1% for 10 min. Secondary antibody, rabbit anti goat IgG 
conjugated with horse radish peroxidase (Santa Cruz Biotechnology) diluted in 1:2000 using 
5 % milk /1 x TBS/Tween 0.1 % was added to the membranes and incubated for 1 hour RT. 
Membranes were wash with 1 x TBS/Tween 0.1 % for 10 mins. Fluorescence signal was 
detected using Pierce ECL plus western blotting substrate (Thermo Scientific). 
 
2.4  Drug concentrations 
2.4.1  For cell proliferative assay  
Drug concentrations used were: Camptothecin (0.1- 10 µM) for all cell lines, Pyridostatin 
(10 µM for U2OS, 0.25 µM for HCT116, 10 µM for HCT15, 1.0 µM for COLO205) and 
Braco-19 (1.5 µM for HCT116). 
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2.4.2  For immunofluorescence 
U2OS and HCT15 were treated with 10 µM of CPT and 10 µM Py in single drug treatment 
as well as co-treatment. 
2.5  In vitro drug treatments 
Two types of assay were carried out to evaluate their antiproliferative effects: 1) Single drug 
treatment with only CPT for 2 hrs, Py or Braco-19 for 24 hours in different cell lines 2) Co-
treatments of CPT for 2 hrs followed by Py or Braco-19 for further 24 hrs. The effect of 
treatment sequence was investigated. Cells were either first treated with CPT followed by Py 
or Braco-19 (Figure 21a) or Py treatment followed by addition of CPT (Figure 21b).    
A sufficient number of exponentially growing cells were used to avoid confluence of the 
culture during the treatments. Cells were seeded at 20,000 cells/well in Falcon 48-well 
plates. All treatments started 24 hrs after seeding. Cells were either treated with single drugs 
or co-treatments. After treatment ended, the drugs were replaced with fresh medium, and the 
cultures were maintained for another 72 hrs before the cell viability quantification. 
Experimental control was always treated with the same amount of DMSO as used in the 
corresponding experiments. 
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Figure 21. Diagrammatic depiction of co-treatment combinations. a) Py/CPT. Cells were treated 
with a drug mixture of Pyridostatin (10 µM) and CPT (10 µM) for 2 hrs after 24 hrs of seeding. 
Drugs were removed (indicated by blue arrow) and cells were further treated with Pyridostatin alone 
for 24 hrs. b) CPT/Py. Cells were treated with Pyridostatin (10 µM) for 24 hrs and further 2 hrs of 
treatment with the addition of CPT 10 µM. All drugs were removed after treatments in (a) and (b) 
and cells were left to grow for further 3 days. The MTT assay was performed to obtain cell survival 
data.  
 
2.6  MTT assay 
The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) colorimetric 
assay is commonly used to determine mitochondrial reductive function and hence it is used 
as an indicator of cell death or inhibition of growth. MTT was performed on cells which 
were left to grow for another 72 hrs after drug exposure. This was to provide a more 
accurate indication of the inhibition of growth caused by drug cytotoxicity rather than other 
situations, such as the cell quiescence, metabolic stopping, or induction of apoptosis. All 
assays were performed in duplicate. 200 µl of MTT solution (1 mg/ml in PBS, Sigma) was 
added to each well and incubated for 2 hrs. Medium was subsequently removed from wells 
and resulting formazan crystals solubilised in 300 µl of DMSO. Culture plates were rocked 
a) 
b) 
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gently for 30 mins to solubilise before measuring the optical density using a microplate 
reader at 595 nm. 
2.6.1  Interpretation of MTT assay 
The cell survival for each treatment condition was obtained from the absorbance values. 
Each absorbance value from treated cells is normalized against a negative control (cells with 
no drug treatment). Normalized values depicting the survival rate of cells is then used to 
compute the IC50 values. 
 
Ab = absorbance of blank 
Ac = absorbance of negative control. 
 
2.7  Half-maximal inhibitory concentration, IC50 
IC50 is the molar concentration of an inhibitor that produces 50 % of the maximal possible 
inhibitory effect of that agonist. The action of the agonist may be stimulatory or inhibitory. 
IC50 of all cell lines were obtained using GraphPad Prism 5. Data from proliferation assay 
were analysed using nonlinear regression of log dose-response. The program finds the best-
fit values of the parameters from the model to the obtained data from MTT assay.   
2.8  Putative G4 motifs 
Two set of genes were chosen for this analysis. These genes were obtained from the 
previous genome-wide study on the effects of CPT. One of the gene sets consisted of list of 
225 promoters which were found to display CPT-induced antisense transcription. Another, 
consisted of 253 genes which showed no antisense transcription. Sequences were 
downloaded from UCSC Genome browser. For each gene sequence, the transcription start 
site (TSS) was identified. The regulatory regions flanking different parts upstream and 
downstream of TSSs were downloaded and analysed in the QGRS for putative G4 
structures. The analysed sequences were from 5000bp flanking upstream of TSS (-5000 to -
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1), intergenic regions flanking 500bp and 1000bp downstream of TSS (+1 to +500 and +1 to 
+1000, respectively) and finally 5000bp downstream of 3’ end. The presence of putative G4 
motifs in genes was investigated using the QGRS mapper [Kikin et. al., 2006]. G4 motifs 
G3+ N1–7 G3+ N1–7 G3+ N1–7 G3+ were searched in designated regions of a gene namely within 
-5000bp upstream of TSS, +500bp, +1000bp downstream the transcription start-site and 
5000bp downstream from transcription termination. The QGRS was set to find putative G4 
structures with at least 3 guanines and constraining loop lengths of the G-quadruplex to a 
maximum of 7 bases. 
2.9  BG4 plasmid 
BG4 plasmid containing the sequence specific for G4 structure was given as a gift from 
Professor Balasubramanian, University of Cambridge [Biffi et. al., 2013]. BG4 was then 
transfected in E.coli bacterial expression system to express antibody specific for the 
detection of G4.   
2.9.1  Preparation of competent cells 
BL21(DE3) cells, incorporated with T7 promoter expression system, is capable of producing 
more protein than any other bacterial expression system. The strain is a specially modified 
BL21 that will express genes from the T7 promoter. It is deficient in 2 types of proteases, 
Ion and ompT. The Ion protease is an intracellular protease that E. coli makes to degrade 
extracellular proteins. It degrades the protein after cells are lysed. E. coli is a living system 
and needs to be able to turn over protein and feed on peptides to stay healthy and productive.  
Escherichia coli strains, BL2(DE3) was inoculated in SOC medium at 1:100 dilution and 
was let to grow for 2-3 hrs at 30 oC. This was to synchronize the cells and to improve its 
competent efficiency. The cells were grown at 37 oC until OD600 is between 0.37 - 0.40. This 
OD value corresponded to the log phase growth of the bacteria, when the T7 promoter is 
repressed to prevent expression of endogenous protein. The bacteria were then pelleted for 
10 mins at 4000 rpm and resuspended in Transformation buffer (in 40 ml). Bacteria 
suspension was left in the cold room for 45-60 mins with continuous agitation. Pellet 
bacteria for 10 min at 4000 rpm. Cells were resuspended in 10ml of transformation buffer 
and 7 % DMSO (700 µl). Freeze cells in aliquots of 250 µl at -80 oC. 
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2.9.2  Transformation of BG4 plasmid 
Competent cells kept in –70 ˚C was placed on ice for 5 mins or until just thawed. A DNA 
concentration of 1-50 ng (in a volume not greater than 5µl) was added to the competent cells 
by moving the pipette tip was moved through the cells while dispensing and quickly flicked 
the tube several times without vortexing. The tubes were immediately returned to ice for 5–
30 mins. Cells were heat-shock for 15 seconds in a water bath at exactly 42 ˚C without 
shaking. The tubes were immediately placed on ice for 2 mins after which 450 µl of room-
temperature SOC medium was added to each transformation reaction, and incubated for 60 
mins at 37 ˚C with shaking (approximately 225 rpm). The tubes were laid on their sides and 
taped to the platform for best transformation efficiency. 100µl of undiluted cells and 1:10 
and 1:100 cell dilutions were plated on antibiotic plates and incubated overnight at 37˚C. 
2.9.3  Preparation of BG4 antibody 
The induction of BG4 protein expression in E.coli was performed using the autoinduction 
method as described by Studier (2005), which requires a high bacterial density. For initiation 
culture, transformed-BL21 cells were inoculated in 2 ml of 2 x TY media + 2 % glucose + 
50 mg/ml kanamycin. Cells were grown overnight at 200 rpm at 30 oC. 
The initiation culture was inoculated in 100 ml auto induction media and let to grow at 37 oC 
at 250 rpm for 6 hours. The cell culture was pelleted for 30 min at 4 oC at 4000 g. The pellet 
was resuspended in 8ml TES and left on ice for 10 mins. A further 12 ml TES diluted 1:5 
was added into mix and left for 15 mins on ice. Cells debris was discarded by spinning down 
for 10 mins at 8000 g at 4 oC. At this point, the solution contained a protein mixture of 
endogenous protein and BG4 antibody. BG4 was purified by using silica-based resin 
(Protino® Ni-IDA) pre-charged with Ni2+ ions. Since BG4 is tagged with polyhistidine, the 
protein would be bound by the immobilized Ni2+ on the resins. One gram of resin was 
weighed and packed into a column. The resin was then equilibrated in PBS, pH 8.0. The 
protein solution was added to the pre-equilibrated column and was allowed to drain by 
gravity. To ensure higher BG4 binding, the flowthrough was collected and was re-added to 
the column.  The column was washed twice with cold PBS/100 mM NaCl/10 mM imidazole, 
pH 8.0 and drained by gravity. Elution was done in a new collecting tube by adding 
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PBS/250 mM imidazole, pH 8.0. The eluted antibody solution was dialysed overnight in 
PBS, pH 8.0 in cold room. The BG4 antibody is stored at 4 oC for few weeks. 
 
2.10  Immunofluorescence 
 
2.10.1  Detection of G-quadruplex 
The U2OS and HCT15 cells were seeded at density of 100,000 and 80,000 cells, 
respectively. After 24 hrs of seeding, cells were subjected to CPT, Pyridostatin or Braco-19 
treatment. The cells were then fixed in methanol/acetic acid (3:1) and permeabilized with 
0.1 % Triton-X100/PBS. After blocking in 2 % milk/PBS, immunofluorescence was 
performed using standard methods with 1:30 of BG4, 1:800 anti-FLAG (No. 2368, Cell 
Signaling Technology) and 1:1000 anti-rabbit Alexa 594-conjugated (A11037, Invitrogen) 
antibodies. Slides are counterstained with DAPI (5 mg/ml) for 30 mins. After briefly washed 
with ddH2O, the slides were mounted by Molwiol (Sigma Aldrich) and left to dry at room 
temperature before transferring to a 4 oC fridge for storage. The images were acquired by 
Nikon Ti-E microscopy equipped with A1R confocal system. Fluorescence quantitation 
analysis was performed using ImageJ software with the following formula: Corrected Total 
Cell Fluorescence=Integrated Density - (Area of selected cell X Mean Fluorescence of 
Background Readings) 
2.10.2  Detection of R-loops 
The U2OS cells were seeded at density 100,000 cells on glass coverslips. After 24 hrs of 
seeding, cells were treated with CPT and Pyridostatin. The cells were washed with ice cold 
PBS and fixed with ice cold methanol for 10 mins. After washing 3 x 5 mins with PBS, cells 
were blocked with 1 % BSA/PBS for 1 hr and followed by incubation with 1:50 of 
DNA/RNA hybrid antibody, S9.6 and detected by 1:800 of goat anti-mouse Alexa 594-
conjugated (A11005, Invitrogen) antibodies. Slides were counterstained with DAPI 
(5mg/ml) for 30 mins. After briefly washed with ddH2O, the slides are mounted by Molwiol 
(Sigma Aldrich) and left to dry at room temperature before transferring to a 4 oC fridge for 
storage. The images were acquired by Nikon Ti-E microscopy equipped with A1R confocal 
59 
 
system. Fluorescence quantitation analysis was performed using ImageJ software with the 
following formula: Corrected Total Cell Fluorescence=Integrated Density - (Area of selected 
cell X Mean Fluorescence of Background Readings). 
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Chapter 3  
Results 
 
3.1 Differential Sensitivity of the Human Cancer Cell Lines to Camptothecin, a DNA 
topoisomerase I poison  
The cellular growth rate was measured for all the cell lines studied to evaluate their 
growth characteristic for establishing optimal experimental conditions. A typical cellular 
growth starts with a lag phase after reseeding. This phase could take a few hours to 48 hrs to 
recover from the trypsinization and activation of cellular regulation to rebuild its 
cytoskeleton and secretion of extracellular matrix to establish a linkage between the cells 
and the propagation substrate.  Upon completion, the cells enter growth cycle and eventually 
reaching the log phase. It is this phase that the effect of drugs treatment is studied. As an 
example, a cellular growth curve of colon cancer HCT116 cell line is reported in Figure 22. 
The HCT116 cells were harvested and seeded in a 24-multiwells plate at different 
concentrations per well, the lowest concentration seeded was 10,000 and highest was 
120,000 cells per well. At a fixed growth area of 2 cm2 each well, cell concentration of 
120,000 displayed a short lag-phase in the first 24 hrs of re-seeding and entered into 
logarithmic growth phase. Cells reached a short plateau at time 50 hrs and were likely to 
enter a cell death phase. For lower seeded cell numbers, the curve was similar but the initial 
gap (lag phase) increases before the logarithmic phase. Thus, a cell concentration of 20,000 
was chosen for cell killing assay as it allows enough time to measure cell growth inhibition 
following drug treatments.  
Similar experiments were performed with HCT15, U2OS and COLO205. They have 
displayed similar cellular growth characteristics for the different cell concentrations. This 
corresponded well to the reported cell doubling times for these cells line [Goldwasser et. al., 
1995; Fallica et. al., 2012] that is between 20 - 24 hrs. Hence, a concentration of 20,000 was 
chosen and used for all cell lines. 
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Figure 22. HCT116 cell growth curve. Graph showing a cell growth curve of different cell concentrations 
seeded in 24-multiwell plates. Cells were trypsinized and left for 24 hrs before counted every 12 hrs. The cell 
growth is indicated by the numbers of cells. Values are means ± S.D. of at least 3 wells for each time of 
calculation. 
 
 
Figure 23. Cell survival after 2 hrs of CPT exposure. Three different cell lines; HCT116, COL205 and HCT15 
were exposed to CPT after 24 hrs of seeding. Camptothecin concentrations between 0.01 to 10 µM were 
treated on cells for the indicated times (a) and (b). A control was use where cells were untreated. The cells 
were left to grow for 3 days after removal of drugs and the MTT assay was performed. Percentage of cell 
survival was obtained from absorbance values that were normalized to the control untreated cells. Values are 
mean ±S.D. of 2 - 4 wells of 2 independent experiments.  
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Upon understanding the cellular growth characteristics, we have investigated the 
sensitivities of COLO205, HCT116 and HCT15 to CPT treatment. These cell lines, despite 
originated from the colon cancers, showed different chromosomal ploidy mutations and 
exhibit natural differences in CPT sensitivity. Both HCT15 and HCT116 derived from a 
colon carcinoma while COLO205 was originated from a metastastic ascite fluid. Treatments 
of different CPT dosages were carried out for 2 hrs in all cell types. Cells with no treatment 
are used as experimental control. The survival of cells after CPT treatment was determined 
using the MTT assay. CPT exhibited marked cytotoxic effects in different colon cancer cell 
lines. COLO205 and HCT116 were most sensitive to CPT with IC50 less than 0.1 µM and 5 
µM CPT, respectively (Figure 23). HCT15 was found to show the least sensitivity towards 
CPT with minimal drug activity at 2 hrs of treatment. The U2OS cells have sensitivity 
between HCT116 and HCT15. Cell exposure to CPT for 1 hr has yielded similar responses. 
These cell lines have been reported for their differences in sensitivity towards CPT and the 
obtained observations were in agreement with the previous publication [Goldwasser et. al., 
1995].  
As Top1 is the sole target of CPT, I have then determined Top1 contents in these cells to 
understand if the differential sensitivity of cells towards CPT could be due to the different 
amount of cellular Top1. Hence, western blot experiments were performed on a whole cell 
lysate to evaluate the cellular Top1 levels in all colon cancer cell lines. Total protein was 
extracted from these cell lines was electrophoresed using a polyacrylamide gel. The 
presence of Top1 in these cell lines were detected using a Top1 antibody while an Actin 
antibody was used as loading control. The Top1 signal from each cell line was measured 
using ImageJ. Results showed that Top1 is detected in all 3 cell lines (~ 100 kDa). 
Additional band was detected at 70 kDa, indicating proteolysis of Top1 protein (Figure 24a). 
The amount of Top1 and its proteolysed form were quantified based on its signal intensity. 
Using ImageJ, Top1 signals were quantitated 3 times and the averaged mean values of Top1 
were normalized against the actin signal to even-out protein loading error. Normalised Top1 
signal is represented in Figure 24b. HCT116 has slightly lower Top1 signal comparing to 
HCT15 and COLO205 (which have almost the same amount of Top1). However, the 
differences in Top1 among these cell lines are not statistically significant (t-test, p>0.05), 
showing that the amount of Top1 in the cells is not the determinant factor of drug 
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sensitivities of the studied cancer cells, in agreement with previous studies [Perego et. al., 
1996;  Goldwasser et. al., 1995]. The U2OS cells, having CPT sensitivity between HCT116 
and HCT15, were not evaluated in this comparison as it has a different histological origin 
(ovary), and therefore it is not homogenous with the other studied lines. Our findings and 
published data thus suggest that additional mechanisms may modulate the enzyme catalytic 
activity, and hence the response to the drug and eventually the cell sensitivity to CPT [Roy 
et. al., 2014].  
 
 
Figure 24. Western blot for Topoisomerase 1 detection in HCT116, HCT15 and COLO205. a) A 
polyacrylamide gel picture showing Top1 at 100 kDa and a loading control, Actin (42 kDa). Additional bands 
were observed at 70 kDa, indicating of Top1 proteolysis. b) Graph showing the amount of Top1 in each cell 
line. Signals were quantified using Image J (NIH). Each value was normalized against the loading control, 
Actin. 
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3.2  Differential Sensitivity of Human Cancer Cell Lines to Pyridostatin, Braco-19 and FG, 
agents that bind to G-quadruplex 
 
Figure 25. Cytotoxicity of Pyridostatin, Braco-19 and FG. a) Cytotoxicity of Pyridostatin in HCT116, 
COLO205, HCT15 and U2OS. A 20,000 cells were seeded and treated with 0.1 µM to at least 10 µM of 
Pyridostatin (except U2OS, a maximum of 20 µM was tested) for 24 hrs. b) Cytotoxicity of Braco-19 and FG 
in HCT116. Twenty-thousand cells were seeded and treated with 1.0 µM to 50 µM of Braco-19 for 6 and 24 
hours while for FG 1.0 µM to 200 µM. Cells in (a) and (b) were left to grow for further 96 hrs after treatment. 
The MTT assay was performed. Untreated cells were used as controls. Cell survival was obtained from 
absorbance values at 595 nm (A595) of treated cells that were normalized against the values of untreated cells. 
Values are mean absorbance±S.D. of at least 3 - 4 wells in 2 independent experiments.  
 
Owing to the previous findings on CPT early effects in stimulating the formation of R-loops 
and associations that suggest G4 structures are modulated during transcriptional stress, we 
have hence use G4 binders as pharmacological tool to study the modulation of G4 in 
transcription. I have first started to investigate the cell sensitivity of G4 binders in all the cell 
lines, used in the previous sections. The cells were tested for their sensitivity to G-
quadruplex binders. Cell proliferation assays were performed on different cell lines with G4 
binders, ie: Pyridostatin, Braco-19 and FG. The cells lines, HCT116, COLO205, HCT15 and 
U2OS, were treated with Pyridostatin for 24 hrs at a concentration between 0.1 – 20.0 µM. 
Results showed that among the different colon cancer cell lines, HCT116 is most sensitive 
cell lines to Py followed by U2OS and COLO205. The least sensitive cell line, HCT15 has 
almost no detectable cytotoxic activity (Figure 25a). Albeit displaying resistance to 
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Pyridostatin and CPT, the use of both HCT15 and U2OS for synergistic studies between G4 
and Top1 can be interesting. The use of them would display a clear interaction, if any, 
between Top1 and G4.  
These observations were preceded using Braco-19 at different time exposures. Cytotoxicity 
of Braco-19 was investigated on HCT116 for 6 and 24 hrs of drug exposures. Both 
exposures showed similar reactivity with a higher cytotoxicity at 24 hrs of treatment, IC50 of 
approximately 35 µM (Figure 25b). The IC50, however, could not be determinable at 6 hours 
of treatment in the tested range of concentrations. Exposure of HCT116 to FG for 24 hours 
showed similar response as in Braco-19.  
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3.3  Synergistic interaction between Pyridostatin and CPT sensitizes cells towards apoptosis  
 
 
Figure 26 (continue next page) 
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Figure 26. Log-dose versus response graphs for different cell lines. a) HCT116; b) COLO205; c) U2OS; and 
d) HCT15. Log-dose versus response graphs were computed from normalized absorbance values obtained from 
MTT assays using GraphPad Prism5. Nonlinear regression model was used to find the best fit curve in the log 
concentration and response data. The IC50 values were computed from these curves. 
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 HCT116 COLO205 HCT15 U2OS 
CPT  
(uM) 
Py 
(uM) 
Py/CPT CPT/Py Py/CPT CPT/Py Py/CPT CPT/Py Py/CPT CPT/Py 
0.1-10.0 0 2.584 0.3362   7.936 2.454   
0.1-10.0 0.25 1.691 0.2465   2.094 0.986   
0.1-10.0 0   0.1987 0.0614     
0.1-10.0 1.0   0.0495 0.0150     
0.1-10.0 0       16.50 2.813 
0.1-10.0 10.0       0.559 0.1296 
Table 1. Half-maximal inhibition concentration (IC50) for each cell line. Table showed IC50 of CPT before 
and after co-treatment with Pyridostatin. The values were computed from cell survival rates in different cell 
lines using GraphPad Prism5. 
 
  
Figure 27. Graphs showing IC50 values for CPT and Pyridostatin co-treatments in different cell lines. a) Co-
treatment Pyridostation/CPT; b) Co-treatment CPT/Pyridostatin. The IC50 values for CPT computed from log-
dose versus response graphs were used to show their reductions when cells were co-treated with Pyridostatin, 
regardless of its sequences of treatment. 
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Figure 28. Fold change of IC50 for CPT in co-treatments of different cell lines. a) Normalized IC50 of co-
treatments to CPT treatment alone were obtained for each cell lines. The reduction of IC50 can be seen across 
tall cell lines and regardless of treatment sequences. b) Fold reductions of IC50 for CPT after co-treatment were 
then calculated as depicted in the table for each cell lines. 
 
Extensive reviews on G-quadruplex on their roles in gene regulation based on in vitro 
studies [Broxson et. al., 2011; Muller et. al., 2010; Cogoi et. al., 2006; Siddiqui-Jain et. al., 
2002] and their non-random putative distribution in the human genome [Zhang et. al., 2013; 
Huppert et. al., 2008], have sparked tremendous interests in this area. One of the recent 
findings have highlighted the interactions between Top1 and G4 in solid tumors. G4 binder 
on the telomeric region, RHPS4, in combination with camptothecin was shown to display 
synergistic effect on the antitumoral activity, hence, putting forward a hypothesis that both 
CPT and RHPS4 target G-strand of telomeric DNA especially during replication. Topologic 
aberrations during telomere replication might require more Top1 to be resolved and the 
stabilized G4 due to RHPS4, must be disrupted for replication to proceed [Biroccio et. al., 
2011; Leonetti et. al., 2008]. These studies have given important clues on the interactions 
between Top1 and G4 structures. As an initial attempt to look into this, co-treatments 
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experiments were designed to look at drug synergism in cancer cell lines from the colon 
origin (HCT116, COL0205 and HCT15) and osteosarcoma (U2OS).  
From previous cytotoxicity profiles, these cell lines posed different sensitivities towards 
CPT and G4 binders (Table 1). Interactions were investigated for their effect on different 
sequence of treatment since Leonetti et. al. (2008) reported a treatment sequence-dependent 
synergism.  Treatments were performed as described in Methods. The cell survival obtained 
from the combination treatments were used to generate the log-dose versus response curves. 
Log-dose versus response curves showed a myriad magnitude of cell proliferation for co-
treatments across different cell lines (Figure 26). Magnitude of reduction is greatest in U2OS 
comparing to HCT15, COLO205 and HCT116 showing the least reduction (Figures 27 and 
28). The IC50 of CPT was reduced after co-treatments in all cell lines (Table 1). The IC50 for 
HCT116 with CPT treatment alone is 2.581 µM, reduced to 1.691 µM when co-treatment 
was performed with Py/CPT. Cell proliferation was also reduced in treatment condition 
CPT/Py (from 0.3362 µM to 0.2465 µM), reduced 1.5x and 1.4x respectively for the 
treatment sequences. For COLO205, IC50 for CPT alone is 0.07774 µM was reduced to 
0.02331 µM in Py/CPT. For CPT/Py, the IC50 is 0.05475 µM and reduced to 0.01636 µM in 
co-treatment.  In term of fold reductions, both treatment sequences showed a similar fold 
reduction across cell lines (Figure 28).  
The U2OS showed greatest magnitude of IC50 reduction, 29.5x and 21.7x, although the cell 
line has the least sensitivity towards CPT and Py. IC50 for CPT alone was 16.54 µM and 
reduced to 0.7051 µM in Py/CPT while for CPT/Py, IC50 was reduced from 2.811 µM to 
0.1422 µM (Table 1). Similarly like U2OS which showed least sensitivity to CPT and Py, 
co-treatments have enhanced reduction of IC50 by 3.8 and 2.5 times for both treatment 
sequences.  
It is also noted that IC50 for CPT alone was different schedule experiments (Figure 27, left 
vs right panels). Depending on the exact combination treatment, CPT treatment was only 
started 48 hrs after cell seeding in the case of CPT only which started simultaneously when 
CPT was added into the 24 hrs Py-treated cells for Py/CPT combination. However, for 
CPT/Py sequence of treatment, CPT treatment started simultaneously after 24 hrs of seeding 
for both treatment conditions, ie; CPT only and CPT/Py combination. This difference is 
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most likely due to different cell-cycle distribution of cells after 48 hours of seeding as 
compared with 24 hrs. Moreover, Figure 3 also shows that cells are entering into its 
logarithmic phase at the 42nd hr. Cells are still in the lag phase in the first 24 hrs after 
seeding. Since CPT is most effect at S-phase cells, it is likely that cells entering the 
logarithmic phase of the growth are mostly cells in S-phase, hence the higher sensitivity to 
CPT treatment.  
The potentiation of CPT cytotoxicity by Pyridostatin across cell lines is indeed a general 
event and the observation agree to the earlier reports. There is, however, no significant 
different between sequence of treatment. These results suggest that combination of Top1 
inhibitor with G4 binder make cell unable to recover from drug-induced cytotoxicity.  
Stabilization of G4 by Pyridostatin decreases cell proliferation and causes cell to accumulate 
in G2 phase of the cell cycle, elicited DNA damage response activation such as 
phosphorylation of histone H2AX on Ser-139 [McLuckie et. al. 2013; Rodriguez et. al. 
2012].  
3.4  Synergistic interaction between other G4 binders and CPT  
Using two other G4 binders, similar cell killing assay were carried n U2OS to confirm 
observations seen in Pyridostatin and CPT co-treatments. The potentiation of CPT effect by 
Pyridostatin was tested using Braco-19 and Bis-guanylhydrazone diimidazo[1,2-a:1,2-
c]pyrimidine (FG) in U2OS cells. Similarly like the previous co-treatment experiments with 
Pyridostatin, U2OS cells were exposed to G4 binders after and prior to CPT exposure. Co-
treatment of CPT with both G4 binders showed that once again, IC50 of CPT is reduced in 
co-treatmen, indication an elevation of CPT cytotoxicity in co-treatments. For Braco-19, 
IC50 of CPT was reduced 9.3 and 2.5 times with Braco-19 exposure before and after CPT 
treatment. The IC50 for CPT was reduced 3.6 and 9.9 times in co-treatment with FG (Table 
2). These observations confirmed those of Pyridostatin co-treatments, hence showing that 
the potentiation effect in co-treatments is not limited to Pyridostatin but all G4 binders. 
Similarly, the sequence of co-treatments was not seen to be significant. Potentiation could 
also indicate interactions between G4 and Top1 that the stabilization of G4 and Top1 
inhibition disrupt cell regulations which lead to apoptosis.  
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Figure 29. Log-dose versus response graph for Braco-19 in HCT116. a) Braco-19/CPT co-treatment; b) 
CPT/Braco-19 co-treatment. Log-dose versus response graphs were computed from normalized absorbance 
values obtained from MTT assays using GraphPad Prism5. Nonlinear regression model was used to find the 
best fit curve in the log concentration and response data. The IC50 values were computed from these curves. 
 
 
Figure 30. Log-dose versus response graph for Bis-guanylhydrazone diimidazo[1,2-a:1,2-c]pyrimidine 
(FG) in HCT116. a) FG/CPT co-treatment; b) CPT/FG co-treatment. Log-dose versus response graphs were 
computed from normalized absorbance values obtained from MTT assays using GraphPad Prism5. Nonlinear 
regression model was used to find the best fit curve in the log concentration and response data. The IC50 values 
were computed from these curves. 
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Fold  
change 
Py →CPT CPT → Py 
Braco-19 9.3x 2.5x 
FG 3.6x 9.9x 
 
Table 2. Fold reductions of IC50 for CPT in co-treatments. IC50 obtained from log-dose versus 
response graphs for Braco-19 and FG were normalized to IC50 of CPT alone. The fold reductions of 
IC50 in co-treatments were calculated for each compound in HCT116 cells. 
 
3.5  Putative G-quadruplex motifs on genes with CPT-induced antisense transcripts 
Putative G-quadruplex (G4) motifs have been reported across the G-rich region of the 
genomic DNA amounting to 376,000 [Rodes et. al., 2009]. The frequent G4 occurrence in 
telomeric regions, gene body and gene control regions suggest a functional correlation with 
gene activity [Zhang et. al., 2013; Huppert et. al., 2007]. Further to look into the interactions 
between Top1 and G4 structures, I have sought to predict formation of G4 structures 
putatively by searching for G4 motifs in the genes which has been shown to display 
antisense transcription, activated by CPT-inhibited Top1 [Marinello et. al., 2013]. The 
distribution of the predicted G4 structures was then analysed. The information would enable 
us to ascertain whether putative presence of G4 motifs and its distribution in the gene could 
indicate possible correlation between G4 presence and dynamic effects of Top1 on divergent 
transcription at CpG-islands promoters. Putative G4 was predicted using QGRS mapper 
[Kikin et. al., 2006] with high stringency as reported by Huppert et. al. (2006 and 2008) to 
search for G3+N1–7G3+ N1–7 G3+ N1–7 G3+ motifs in the DNA sequences. The QGRS was set to 
find putative G4 structures with at least 3 guanines and constraining loop lengths of the G-
quadruplex to a maximum of 7 bases.  
All 225 genes that were found to have antisense transcription induced by CPT [Marinello et. 
al., 2013] and a set of randomly selected genes, which showed no antisense transcription 
(253 genes), were analysed for the presence of putative G4 motifs. For each gene, the 
putative G4 motifs were categorized into pre-TSS (5000 bp upstream of transcription start 
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site), +500 bp downstream of TSS, +1000 bpdownstream of TSS and 5000 bp downstream 
of transcription termination site.  
The occurrence of putative G4 motifs is found to be particularly higher in promoter genes 
with no antisense transcription. More than half of these genes have at least one G4 motifs at 
pre-TSS and +1000 bp TSS (Figure 31). Overall analysis of the putative G4 motifs looks to 
be enriched on the upstream region of the TSS. Interestingly, the occurrence of G4 motifs is 
found less prevalent in genes that displayed antisense transcription particularly on the 
template strand. These coincide with available genome wide data from Marinello et. al. 
(2013) that the accumulation of RNAPII antisense transcription occurs mainly in the 
upstream of TSS of divergent CpG island promoter, approximately 5000 bp upstream of 
TSS. Furthermore, analysis in the non-template versus the template strand (Figure 31b) 
reveals that approximately 55% of the genes contain at least one G4 motifs in the pre-TSS 
region of non-template strand compared to the same region of template strand. Our data 
corresponded well with those from a genome wide study by Zhang et. al. (2013). These 
observations implied a significant important in presence of G4 motifs which could affect the 
transcriptional activity of active promoters. The non-random enrichment of G4 motifs, 
particular on the upstream region of TSS could be a mode of downstream transcription 
activity sensing by G-quadruplex formation and its direct effect on DNA. The fast 
propagation of negative supercoiling generated by a proximal or distal downstream 
transcription or DNA tracking event induces a G-quadruplex formation at the PQS site and 
subsequently affects protein recognition and hinders protein translocation along the DNA. 
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Figure 31. Putative G-quadruplex motifs. a) An overview of putative G4 motifs. Sequences downloaded 
from UCSC Genome Bioinformatics website were analysed for the presence of putative G4 motifs. A total of 
225 promoters with antisense transcriptions and a set of 253 genes randomly chosen gene which showed no 
antisense transcription were analysed for putative G4 motifs using QGRS mapper. Regulatory sequences 
flanking 5000bp upstream of transcription start site (TSS), +500 bp and +1000 bp downstream of TSS plus 
5000 bp downstream of 3’end were scanned for putative G4 motifs.; b) Diagram depicting the positions of the 
genome where G4 motifs were investigated in a gene.  
 
3.6  Preparation of the antibody against G-quadruplex  
The availability of G-Quadruplex specific antibody has provided valuable analytical tool to 
study the biological and therapeutical role of G4 structures [Handerson et. al., 2014; Biffi et. 
al., 2013]. In this study, the interplay between Top1 and G4 and the presence of putative G4 
motifs have been established in cancer cells. As such, it is critical that these G4 can be 
confirmed through its visualization in vivo. We have, hence, proceeded to visualize G-
quadruplexes in cells using a monoclonal antibody specifically directed against G4 motifs, 
named BG4, is engineered by Biffi and co-workers [Biffi et. al., 2013]. The G4-specific 
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antibody is built as single-chained variable fragment fusion protein (scFv) that consists of 
the smallest functional antigen-binding domain of an antibody (~ 30 kDa) formed by 
engineering the heavy (VH) and light (VL) domains of the antibodies with a short linker 
polypeptide. Produced by phage display, BG4 was chosen from a library of scFv [Biffi et. 
al., 2013]. The resultant scFV antibody populations were sub-cloned into an expression 
vector (pSANG10), which utilizes the high level expression promoter T7lac, driving 
expression of scFv to the bacterial periplasmic space via a pelBsignal peptide sequence 
[Martin et. al., 2006]. This resulted in the production of antibody that is fused with a six 
histidine tag for one step immobilised metal affinity chromatography (IMAC) and a tri-
FLAG epitope tag for detection. 
To prepare BG4 antibody, the recombinant plasmid is transfected into BL21(DE3) E.coli 
strain that possesses an inducible T7 RNA polymerase that transcribes the gene under the 
control of T7lac promoter. Together with a lac operator sequence is placed downstream to 
the start site of T7promoter to regulate the expression of basal protein expression. The 
presence of small percentage of both glucose and lactose in the auto-induction serves to 
reduce basal transcription and start expression when cells reached saturation. Glucose is 
favored over lactose when both are presence. Glucose reduces cAMP and catabolite 
activator protein (CAP). Under low concentration of cAMP, CAP is not able to bind to 
DNA, thus disabling the function of RNA polymerase. As glucose is depleted, catabolite 
repression is relieved, which leads to a shift in cellular metabolism toward the import and 
consumption of lactose and glycerol. Lactose import results in the production of allolactose 
from lactose by a promiscuous reaction of β-galactosidase. Allolactose then acts as the 
physiological inducer of the lac operon. Lactose is broken down by the lac operon to 
produce allolactose.  Allolactose binds to lac repressor, thus removing it from the operator 
sequence and enabling the establishment of an elongation complex by T7 RNA polymerase 
at a T7lac promoter and substantially kick-starting the protein expression. It places the 
transition from the un-induced to induced state under metabolic control of the expression 
host. This protocol follows an autoinduction protocol for BG4 protein expression (as 
described by Studier, 2005) that is based on the ability of appropriate media to induce 
protein expression in E. coli when cells reach saturation. 
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Induction of protein expression in E.coli strain BL21(DE3) was monitored by taking a small 
amount of bacteria culture (5 ml) at times 0, 3, 6 and 24 hrs. SDS-PAGE of the bacterial 
crude protein lysate showed that, as induction time advanced, bacteria were seen to produce 
higher concentration of protein. Protein expression was visible as soon as 3 hrs of induction, 
which could probably be due to T7 promoter that has a very high activity. 24 hrs of 
induction gave a high concentration of proteins (Figure 32a).In comparison to induced cells, 
protein expression is visibly lower in control cells (not-induced). 
Flowthrough represents the crude lysate that has been passed through the beads. The crude 
protein lysate were let to pass through the bead for 2 times. Electrophoresis on the 
flowthrough showed that both flowthroughs has almost equal intensity of protein.  A second 
flowthrough did not seem to increase the binding capacity of beads. BG4 protein bound to 
the resin was then eluted with cold PBS/250 mM imidazole 3 times and a final elution with 
PBS/500 mM imidazole to ensure all proteins was totally dissociated from the resins. 
Purified antibody is seen mostly in the second and third elutions; these are combined and 
concentrated using Amicon Ultra to obtain higher concentration of antibody. High purity of 
antibody was obtained as no other visible bands are detected except an intense band at the 
molecular size of approximately 37 kDa (Figure 32b). BG4 was totally eluted after the third 
elution and no visible of BG4 was detected in the washing step. 
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Figure 32. a) An SDS-PAGE of crude protein lysate from induced BL21(DE3) for different times. T indicates 
time (hour) of induction. Five mililitres of cell culture was collected from control which were uninduced for 
BG4 protein expression, Induced at T=0, Induced at T=3, induced at T=6 and T=24 were lysed and checked for 
overexpression of proteins using the SDS-PAGE. b) An SDS-PAGE showing purified protein lysate. Black 
arrow indicates the molecular weight where BG4 protein is seen. Eluted BG4 protein is visible at lanes 4 and 5. 
Protein from these lanes is accumulated and concentrated. 
 
3.7  Visualization of G-Quadruplex in living cancer cells 
As a continuation to our previous objective to produce BG4 for visualization of G4 in vivo, 
we have succeeded in expressing BG4 in bacterial expression and obtained a purified 
monoclonal antibody. We then attempted immunofluorescence staining to validate its 
functionality. The U2OS cells were seeded on glass slides and treated with Pyridostatin (Py) 
for 24 hrs at 10 µM. This concentration was used in agreement with published data [Biffi et. 
al., 2013] and the 10 µM of Py was found to display low drug-induced cytotoxic effect on 
U2OS with a 80% of cell survival (Figure 6). Incubation of Py-treated U2OS with BG4 was 
carried out as described in Materials and Methods Section, and was detected by a fluorescein 
conjugated secondary antibody. Results showed that small punctuates of green fluorescence 
signal was seen in both controls and treated cells and they were localized in the nucleus of 
the cells, indicated by a nuclear staining with DAPI. Occasionally, fluorescence punctuates 
could be seen at areas in adjacent to the nuclear membrane, which is probably endogenous 
RNA G4 structures or G4 on RNA which was being transported out to the cytoplasm [Biffi 
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et. al., 2014]. Pyridostatin-treated cells displayed an increase of fluorescence staining as 
compared with control cells when viewed on a confocal microscope (Figure 33). Further to 
confirm these observations, we treated U2OS with Braco-19. Images from confocal 
microscope showed similar images as was seen from Pyridostatin treatment. The increased 
of fluorescence signal is further confirmed by Braco-19 treatment (Figure 34). Quantitation 
of the fluorescence signal showed an increased mean value for both experiment conditions 
compared to control (Figure 35). An increase of 1.5 and 1.8 of ratio fluorescence arbitrary 
unit in Py- and Braco-19 treated cells, respectively, when the fluorescence signal is 
normalized to the control cell (Figure 35b). Another G4 binder, FG was shown to produce 
similar effect on U2OS with an increase signal of 4x compared to normal cells. In addition, 
to control the specificity of FG towards G4 in vivo, we used another compound, named FA, 
which is a closed derivative of FG with few structural differences (Figure 12b, Structure 2), 
but cannot bind G4 motifs [Sparapani et. al., 2010]. FA did not increase nuclear 
fluorescence of BG4 signals. The presence of fluorescence signal in control cells showed 
that stable physiological G4 are present in cells under normal conditions. As BG4 has 
previously been shown to display high specificity towards G4 structures, fluorescence signal 
indicates that the G4 structures formed were stabilised by Py, Braco-19 and FG. Treatment 
with G4 binders has enabled more G4 to be stabilized and hence a higher fluorescence 
signal. These observations indicated the functionality of our G4 antibody and are able to 
detect G4 in vivo. 
Next, we used this G4 antibody to investigate the functional interaction between Top1 
poisons and G4 binders. This might provide initial insights to assess whether transcriptional 
stress caused by CPT is associated with increased negative supercoiling, a condition 
favoring G4 formation. Hence, experiments were designed and carried out to investigate G4 
formation under CPT effect. The U2OS cells were treated with 2 hrs of CPT alone and in 
combination treatments with Pyridostatin. Fluorescence signal for CPT alone show similar 
level with endogenous G4 and lower for co-treatments (Figures 34 and 35). A probable 
explanation to this observation is that the CPT was previously report to show an early effect 
on cells. An exposure of 2 hrs CPT would have caused G4 formed from CPT exposure to be 
resolved by helicases as RNAPII advances towards stalled Top1cc. It is also probably one of 
the homeostastical response towards a topologically balanced DNA structures. However, 
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Braco-19/CPT co-treatment did not show similar observations. Both Braco-19 only and 
Braco-19/CPT treatments showed elevated fluorescence signal compared to control. This 
could be due to the cytotoxic effect from high concentration used for Braco-19 as 
cytotoxicity assay was not tested on U2OS.  
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Figure 33 (Page 81). Stabilization of G-quadruplex by Pyridostatin in U2OS. Images from confocal 
microscope showing G4 structures bound by Py. The U2OS cells were treated with Braco-19 and FG for 24 hrs 
at 10 µM, respectively. The cells were fixed with methanol/acetic acid and subjected to immunofluorescence 
staining. G-quadruplex structures were detected using the BG4 antibody and subsequently its detection using a 
fluorescein-conjugated secondary.  
 
 
Figure 34. Stabilization of G4 by Braco-19 and FG in U2OS. Images from confocal microscope showing G4 
structures bound by Braco-19 and FG. The U2OS cells were treated with Braco-19 and FG for 24 hrs at 10 
µM, respectively. The cells were fixed with methanol/acetic acid and subjected to immunofluorescence 
staining. G-quadruplex structures were detected using the BG4 antibody and subsequently its detection using a 
fluorescein-conjugated secondary. 
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Figure 35. a) Box-plot of the G4 immunofluorescence staining. An * indicates maximum outlier fluorescence 
signal. b) Bar chart showing mean arbitrary fluorescence unit of G4 immunofluorescence staining. 
 
3.8  Rapid formation of G-quadruplex by CPT  
Previous data have shown that CPT-induced Top1ccs increased rapidly after 2 mins of 
treatment and followed by rapid removal at the promoters. The burst of Top1ccs forms a bell 
shaped curve with a peak at 2 mins and reduced thereafter. These, together with indications 
from my previous observations on the formation of G4 that is not increased upon treatment 
with 2 hrs of CPT have raised further questions if CPT effects in the same manner as 
Top1ccs. Hence, this prompted an investigation to look at the G4 formed by CPT in a time-
dependant manner. In the experiment, shorter time exposures to CPT were planned. These 
times also correspond to those used for Top1ccs [Marinello et. al., 2013]. The U2OS cells 
were exposed to CPT for 2 mins, 10 mins and 2 hrs at 10µM. Interestingly, with CPT alone, 
G4 formation peaked at 2 mins and reduced at 10 min and almost back to the level displayed 
by control cells at 2 hrs of CPT exposure (Figure 36). Moreover, G4 formation at 2 hrs of 
CPT agrees well with those from previous experiment (Figure 35). The formation of G4 was 
also investigated in co-treatment Py and CPT. Upon 24 hrs of Py exposure ended, the cells 
were exposed to CPT at different times as used in CPT treatment alone. Likely, G4 
formation peaked at 2 mins and reduced at 10 mins and back to a level as in the control cells 
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for 2 hrs of CPT. These clearly showed a similar dynamic of G4 formation between CPT 
and Py/CPT treatments. All in all, the formation of G4 corresponds to the kinetics as seen in 
CPT-induced Top1ccs. CPT rapidly induced Top1ccs and so as G4 structure. As time of 
CPT is prolonged, both are also removed. G4 formation may be regulated when Top1ccs is 
induced by CPT which leads to the blocking of polymerase escape from promoter regions 
and their removal releases RNAPII allowing pausing escape and simultaneously maintaining 
a more balance DNA topology. 
 
 
Figure 36. G-quadruplex formation in U2OS. a) CPT time-dependant experiment. An * indicates 
maximum outlier fluorescence signal.  b) CPT dose-response experiment. 
 
3.9  Rapid formation of G-quadruplex in CPT is dose dependent 
Khobta et. al. (2006) and Marinello et. al. (2013) have previously reported that the effect of 
CPT is dose specific in HCT116 cell lines. They tested a range of CPT concentrations from 
as low as 0.08 µM to 10 µM and antisense transcriptions were seen at 10 µM of CPT 
treatment. Using this as a reference, the effect of CPT exposure on formation of G4 was 
investigated but in a larger concentration range. Experiment was carried on U2OS cells with 
different dose of CPT. Cells were exposed to 2 µM, 5 µM, 10 µM and 50 µM for 2 mins. 
Different doses of CPT showed an effect similar to the kinetics of Top1ccs, a bell-shaped 
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curve. G-quadruplex is least formed at 2 µM and increases at 5 µM of CPT. The 
fluorescence signal peaked at the exposure of 10 µM CPT but immediately reduced at 50 
µM of CPT (Figure 36b). The results corresponded to those published earlier, hence, once 
again indicating an interesting regulations by Top1 on G4 formation when cells are exposed 
to CPT. 
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3.10  G-quadruplex formation in CPT-resistant HCT15 cells 
HCT15 is one of the colon cancer cell lines used which has been previously established for 
its synergistic relationship between Topo1 inhibitor and G4 binder besides U2OS. The 
synergism relationship was indicated by a significant reduction in the IC50 of CPT when co-
treatments were performed. It is, hence, of interest, to show that this kinetics is not limited to 
only U2OS. The relationship between CPT effects on the G4 formation was investigated in 
HCT15. Cells were first investigated for G4 formation in different CPT time exposures and 
in another, short exposure to different CPT dosage. In the CPT time exposure experiment, 
G4 formation in HCT15 displayed a peak fluorescence at 2 mins and reduced thereafter (10 
mins and 2 hrs) (Figure 37a). In the CPT dose response experiment, G4 is least formed at 2 
µM of CPT and steadily increase at 5 µM and peaks at 10 µM of CPT. The formation is 
however reduced at 50 µM of CPT (Figure 37b). In both cases, HCT15 was also treated with 
Pyridostatin for 24 hrs as control. G4 was shown to be formed and stabilized by 
Pyridostatin.  These observations showed that CPT effect on the formation of G4 is not 
limited to type of cells used. Both experiments in HCT15 showed similar kinetics as in 
U2OS. 
 
 
Figure 37. G-quadruplex formation in HCT15. a) CPT time-dependant experiment. The U2OS cells 
were treated with CPT in different times; b) CPT dose-response experiment. The U2OS cells were 
treated with different concentrations of CPT for 2 mins. 
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3.11  Elevation of R-loops formation in Pyridostatin-treated cells 
R-loops are RNA:DNA hybrid structures, a by-product formed co-transcriptionally which 
are associated with genome instability. Their formation is one of CPT effects seen in cells. 
Previous study by Marinello et. al. (2013) reported that the burst of CPT-induced Top1cc 
paralleled with the formation of R-loops at transcriptionally active promoters. The R-loops 
formation is favored by the increasingly negative supercoiled DNA. Coincide where R-loops 
is present, G4 has been hypothesized to be present. Interestingly, it was shown in the 
previous section that G4 formation induced by CPT, displayed a similar kinetics in 
paralleled to the burst of CPT-induced Top1cc and R-loops formation. Hence, I sought to 
understand further modulation of R-loops formation in DNA damaged cells. The U2OS cells 
were treated with Pyridostatin at 10 µM for 24 hrs. Cells treated with 10 µM of CPT for 2 
mins was used as experimental control for R-loops formation. After drug treatments, R-
loops formation was detected using the DNA/RNA hybrid antibody, S9.6 (Figure 38). All R-
loops fluorescence was shown to be localized to the nucleolus of the cells as visualized by 
the nucleus staining. A small amount of fluorescence was detected in the untreated U2OS 
cells and it increases 1.4 x when cells were treated with CPT for 2 mins, in agreement to 
previous experiments (Figure 39). Much to the excitement, fluorescence signal was 
significantly elevated by 4.5 x in Py-treated cells (Figure 39), leading us to believe that its 
formation could be modulated for DNA damage checkpoint activation. Treatment of cells 
with pyridostatin has been shown to induce DNA damage at specific genomic loci that 
contain putative quadruplex clusters sequences, such as the proto-oncogene SRC. Its G4-
stalling nature by exerting mechanical forces stalls polymerases during transcription as 
indicated by an accumulation in G1 and G2 cells. This triggers transcriptional inhibition and 
elicited DNA damage as indicated by the production of H2AX and cellular markers that 
lead to the ATM-mediated DNA damage response activation [Rodriguez et. al., 2012]. The 
findings demonstrated that R-loops are formed in Pyridostatin–treated cells provide a strong 
indication that R-loops are modulated in response to DNA damage activation. 
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Figure 38. Images from confocal microscopy for R-loops formation. The U2OS cells were treated 
with 10 µM of CPT for 2 mins and 10 µM of Pyridostatin for 24 hrs. Control is cells without any 
drug treatment. The cells were fixed in ice cold methanol and subjected to standard 
immunofluorescence staining protocol. R-loops were detected using S9.6 antibody.  
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Figure 39. R-loops formation in U2OS. Quantification of images captured by confocal microscope 
(Figure 38) using ImageJ, NIH. Box-plot showed R-loops are formed in CPT-treated cells and is 
much elevated in Pyridostatin-treated cells. 
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3.12  Top1cc repair pathway resolves G-quadruplex structures and destabilizes the R-
loops 
In the previous sections, formation of R-loops and G4 were seen to be modulated in 
response to transcriptional stress by Top1 inhibition. To confirm these observations, we have 
sought to look at R-loops and G4 formations after inhibition of TDP1, an enzyme of the 
Top1cc repair pathway [Hubert et. al., 2011; El-Khamisy et. al., 2005]. 
To inhibit TDP-1, I have used the inhibitor, NSC88915, synthesized by Dexheimer et. al. 
(2009). The U2OS cells were incubated with TDP1 inhibitor over for 2 mins, 10 mins, 2 hrs 
and 24 hrs. The R-loops formation was then monitored using S9.6 antibody. R-loops 
formation seemed to be not affected by the short exposure of U2OS to TDP1 inhibitor. The 
level of R-loops is almost at physiological level and is not increase during all tested time of 
drug exposure. G4 formation after TDP-1 inhibition showed a slight increase in the first 2 
hrs. This increment is only minor as compared with the dynamics seen in G4 binder time-
course exposure, both in U2OS and HCT15 cell lines. The formation of G4 is reduced after a 
24 hrs of drug exposure. 
Results showed that the dynamics of R-loops (Figure 40a) and G4 (Figure 40b) formations 
which have been seen earlier in CPT treatment were not reproduced in TDP-1 inhibited 
cells. A small effect, if any, of drug is only seen after a prolonged treatment. Further 
experiments need to be performed to establish whether or not TDP1 has any role in G4 and 
R loop formation, in particular we need to assess the effects of TDP1 inhibitor on G4 and R 
loop levels induced by CPT and pyridostatin. 
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Figure 40. TDP-1 inhibition in U2OS. a) R-loops formation in TDP-1 inhibited U2OS. b) G-
quadruplex formation in TDP-1 inhibited U2OS. 
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Chapter 4 
Discussion  
 
Previous studies from our laboratory have demonstrated intrigue findings on the role 
of Top1 during transcription and on the transcriptional consequences when Top1 is inhibited 
by CPT in human cell lines. Earlier work from the laboratory has unexpectedly observed an 
increase of RNAPII escape from promoter proximal pausing with marked alteration of HIF-
1α co-transcriptional splicing, increased chromatin accessibility and activation/repression of 
antisense transcripts [Baranello et. al., 2009]. 
In addition, CPT can impair the balance of cellular antisense and sense transcripts of cancer 
related HIF-1α. CPT increases transcription of a novel long RNA (5’ aHIF-1α) which is an 
antisense to human HIF-1α mRNA and a known antisense RNA at the 3’-end of the gene. 
Eventually, this CPT effect is further investigated in a genome-wide scale. Consequently, 
the analysis shows that CPT-induced Top1ccs trigger an accumulation of antisense RNAPII 
transcripts specifically at active divergent CpG-island promoters. Likely to the previous 
effects shown by CPT, this phenomenon is replication independent and Top1-dependent 
manner. Moreover, time-course data showed a burst of Top1ccs increased by CPT at 
promoter sites and along transcribed regions, causing a transient block of RNAPII at the 
promoter. Similar time course also shows a transient increase in R-loops in highly 
transcribed regions.  
It is, however, the function of R-loops is unknown although they are implicated in a 
molecular response pathway leading to transcription-dependent genome instability and 
alteration in transcription regulation. Our unpublished data also shows that CPT-induced R-
loops is not limited to nucleoli but also in the mitochondria DNA, although the stability of 
R-loops is more stably formed compared to those formed in the genomic DNA. In both 
scenarios, R-loops are formed particularly in the hypernegatively coiled DNA and G-rich 
regions of DNA. Collectively, these data point to another interesting aspect of CPT effect on 
the regulation of DNA topology. R-loops are three stranded structure which are formed 
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when RNA hybridizes to a complementary DNA strand of a DNA duplex, leaving the 
opposite DNA strand single-stranded. DNA hypernegatively and G-richness of the DNA, 
conditions which favor the formation of R-loops [Aguilera et. al.,  2012; Ginno et. al.,  
2013]; are also found to be favourable conditions for the formation of G-quadruplexes (G4) 
[Sun et. al.,  2009; Huppert et. al., 2008]. G-quadruplex structures are stacked nucleic acid 
structures that can form within specific repetitive G-rich DNA or RNA that have sequence 
motif  G≥3NxG≥3NxG≥3NxG≥3.  Both R-loops and G4 have been shown to be involved in 
regulatory functions in vivo (reviewed in Chapter 1). Despite the numerous reports on the 
existence of G4, earliest reports on the interactions between G4 and Top1 only emerged in 
2000 by Arimondo et. al. and followed by Marchand et. al. (2002) using in vitro studies. 
Both studies have reported that the Top1 is able to bind to intermolecular and intramolecular 
G4 and induces the formation of intermolecular ones. It is shown that Top1 and not TopII is 
able to displace G4-DNA [Arimondo et. al., 2000]. This specificity has also seen that an 
inhibition of CPT-induced Top1 trapping of DNA by G-quartet-forming and G-rich Single-
stranded oligodeoxynucleotides [Marchand et. al., 2002]. In vitro interaction between G4 
binders and CPT have shown to increase cell cytotoxicity in malignant cells [Leonetti et. al.,  
2008; Birroccio et. al., 2010], further establishing compelling evidences of an in vivo Top1-
dependent mechanism of action in G4 formation.  
Our work is focused on the role of DNA topoisomerase 1 (Top1) interactions with G4 
during transcription and its involvement in the Top1-dependent repair pathway. Although, 
we have previously reported extensively on the role of Top1 in transcription in a single gene 
and genome-wide scale, the interactions of Top1 and G4 is less studied in vitro. We have 
hence sought to characterize their interactions including a possible role of Top1 in DNA 
repair mechanism.  
Using different cancer cell lines of colon and osteo origins, we show that they display 
different sensitivity to CPT that is independent from Top1 level (Figure 23), consistent with 
available data [Goldwasser et. al., 2005]. Sensitivity of CPT in cells is defined by a 
parameter, inhibitory concentration (IC50), is an inhibitory concentration to achieve half 
maximal inhibition. Among the cell lines tested, we show that COLO205 has the least IC50 
and HCT15 having the highest IC50 (Table 1). Since Top1 is the specific target for CPT, we 
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look that the level of Top1 in these cell lines. We show that the level of Top1 is not 
predictive for the differential sensitivity in these cell lines as indicated by an insignificant 
Student’s t-test. The sensitivity is rather thought to be correlated directly with the 
intracellular hTop1 activity level since mutations in the Top1 can confer resistance to CPT 
[Gongora et. al., 2011; Li et. al., 1996]. The cell lines also show different response to G4 
binders. The G4 binders are small molecules that are capable to stabilize G4 structures 
preformed in the cells and/or G4 that are formed due to stress. Most of the G4 binders, such 
as RHPS4 [Leonetti et. al., 2008], are well tolerated and have good toxicology profiles. In 
our study, we show that cell exposures to different G4 binders (Pyridostatin, Braco-19 and 
FG) show absence of drug-toxicity except dose-related hypotension (Figure 25). U2OS and 
HCT15 are two CPT-resistant cell lines that shows low or no cytotoxic response to 
Pyridostatin.  
To look at the interactions between Top1 and G4, we co-treat cells with CPT and G4 
binders. Cell cytotoxicity confers by CPT through conversion of Top1 to Top1ccs, display a 
remarkable increase of cytotoxicity when cells are co-treated with G-quadruplex (G4) 
binders. We show that the co-treatment potentiate cell cytotoxicity of CPT regardless of the 
treatment sequences. Potentiation is indicated by a reduced inhibition concentration (IC50) 
with a more profound cytotoxicity in CPT-resistant cell lines, HCT15 and U2OS. Hence, 
indicating a possible molecular mechanism that may be modulated through the interactions 
between Top1inhibitor and G4 binders, leading cell death. The interactions have, in fact, 
been shown in in vivo study that RHPS4 and CPT combination treatment inhibits and delays 
tumor growth in the colon cancer in mice, thus increases survival [Birroccio et. al., 2010; 
Leonetti et. al., 2008]. This cytotoxic consequence of combination drug treatment has open 
new avenues of deducing the molecular effect of CPT in the modulation of DNA topology 
that leads to genomic instability. 
This is further supported by the presence of G4 motifs as determined by computational 
analysis on 225 genes with CPT-induced antisense transcription. G4 motifs are present 
mostly 5000 bp upstream from transcription start site and notably lower in genes body. 
Comparisons between genes with no antisense transcription and genes with antisense 
transcription show that G4 motifs in this region are notably lower in the genes with antisense 
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transcripts. It is however, unclear how this prevalence plays a role in the antisense 
transcription. These promoters have not been curated for their biological ontology as 
classified by Ginno et. al. (2013) which has identified four classes of promoters according to 
their GC skewness. Class IV genes, for instance, represented the likely distribution of PHQS 
which is seen from our analysis (Figure 31) contains gene sets enriched for developmental 
regulators. Nevertheless, our analysis corresponded well with recent bioinformatics analyses 
which show strong bias towards the non-template versus the template strand, in higher 
species [Lam et. al., 2013; Xiao et. al., 2013]. 
Collectively, the cell cytotoxicity and the computational analyses, we have, hence, 
hypothesized that the occurrence of PHQS in genes can be regulated to be functionally 
meaningful in cell regulations. Given the particular trends of G4 distribution in genes that 
display antisense transcription, it is likely that they are regulated by Top1 for transcription 
regulation. We can hence speculate that CPT causes fast propagation of negative 
supercoiling generated by a proximal or distal downstream transcription, which in turn 
induces G-quadruplex and R-loops at the potential G4 forming sites (PQS) sites. These may 
then posed a physical hindrance that affects protein recognition and their translocation along 
the DNA.  
The biological importance of G-quadruplex formation such as transcriptional regulation and 
DNA replication in maintaining genomic stability has been reported extensively. G-
quadruplex structures exist and are stable in human DNA [Lam et. al., 2013]. Consistently, 
our study using an engineered antibody specific for G4 structures shows that G4 structures 
can be readily detected and visualized particularly localized in the nucleoli of cells, even 
without drug treatments (Figures 33, 34 and35). Although so, their molecular functions in 
vivo are not well characterized, in vitro analyses suggest that their formations may pose 
physical obstructions for transcriptional machinery. The KRAS gene, for example, contains 
a nuclease hypersensitive polypurine-polypyrimidine element that is essential for 
transcription. The G-rich strand of this element is able to form G4 as shown by circular 
dichroism (CD) and DMS footprinting experiments. Cogoi et. al. (2006) showed that the 
stabilization of G4 by TMPyP4 (a G4 binder) in this element increases the melting 
temperature of the oligonucleotides that competes with the nuclear protein, hence 
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postulating a transcriptional inhibition effect [Cogoi et. al., 2006]. Similarly, in vitro 
experiment showed that G4 stabilization in the nuclease hypersensitivity element (NHE) III 
of the c-MYC promoter region results in suppression of transcription activation (Yang et. 
al., 2006; Siddiqui-Jain et. al., 2002].  
Intriguingly, CPT exposures in the cells show an increase of G4 formation, noted by an 
increase compared to the controls in the first 10 minutes of treatment and reduced thereafter 
(Figure 35). It shows a rapid uptake by CPT that causes the accumulation of Top1ccs that in 
turn affect DNA hypernegativity. In relation to this, our previous data that shows CPT 
induces a hyperphosphorylation of the Rpb subunit of RNAPII and promote the escape of 
RNAPII from pausing sites after 1 hour of CPT exposure. In this experiment, we see that G4 
is resolved further reduced at 2 hours of CPT, an effect which may probably occur 
simultaneuously with the escape of RNAPII from pausing sites. Consequently, the CPT-
induced Top1ccs may regulate the binding of helicases to DNA to resolve G4 structures, 
although, it is unsure how this is achieved. Arimondo et. al. (2000) and Marchand et. al. 
(2002) were one of the firsts to observe the interactions between Top1 and G4. They 
reported that Top1 binds to intramolecular G4 and induces formation of intermolecular G4 
structures. In certain cases, the formation of G4 is promoted by cleaving DNA duplexes, 
hence, suggesting a possible role of Top1 to prevent higher order of structures during 
transcription or the enzyme activity in RNA splicing. And further strengthening their 
findings, recent studies have reported several G4-specific helicases that are capable to 
resolve these G4 structures [Chen et. al., 2015; Paeschke et. al., 2013; Wu et. al., 2008]. It is 
likely that Top1ccs regulate the recruitment of these helicases to G4 structures to counter-
response the CPT-induced transcriptional stress. 
Moreover, the rapid increase of CPT-induced Top1ccs affect the DNA supercoiling towards 
a more negatively form, induces the transient formation of R-loops. The kinetics of R-loops 
appears to be in parallel with the formation of CPT-induced Top1ccs. This prompted us to 
look at the formation of G4 in response to CPT-induced Top1ccs. To our delight, the 
kinetics of G4 formation appears to be rapidly formed, a kinetics similarly seen to that of 
Top1ccs and R-loops. This rapid response towards CPT exposure has led us to hypothesize 
that Top1ccs can in fact regulate the formation of G4 and this transcriptionally-dependent 
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CPT effect has not been reported elsewhere, hence, can provide a vital piece of information 
in deducing the molecular effect of CPT on transcription. The observation also shows that 
G4 are stable structures given the suitable conditions. It is shown that their formation and 
stabilization are dependent on monovalent cations, specifically K+ and Na+ [Sen et. al., 
1990]. The K+ which is present physiologically stabilizes G4 through the coordination of 
the positively charged cations with the electronegative O6 atoms in the center channel of the 
adjacent stacked G-tetrads [van Mourik et. al., 2005]. Coupled with a favourable topological 
conditions (ie; DNA hypernegativity), the rapid formation of G4 can, hence, be supported. 
The rapid formation of G4 induced by CPT is dose dependent (Figure 36b) where we show 
that a bell curve pattern of G4 formation with a peak at CPT 10uM, a concentration that 
shows antisense transcription in HCT116 [Khobta et. al., 2004; Marinello et. al., 2013]. We 
then extend the investigations in HCT15, a colon cancer cell line that is being shown for 
elevated CPT cytotoxicity upon G4 stabilization (Figure 37). Similar kinetics of G4 
formation is seen, showing that an interaction of Top1ccs with G4 structures is in fact, not 
cell specific but a universal event. We may hence speculate that Top1 modulate DNA 
superhelicity at transcribed active promoters in order to regulate gene activation. 
Moreover, G4 formation is highly elevated in Pyridostatin treated cells, which previous 
study shows increased formation of γH2Ax foci. This effect is also seen in the CPT-resistant 
cell lines, HCT15, indicating that the formation is a general event in response to CPT. We 
also show that Although, G4 has been shown previously to be formed in Pyridostatin-treated 
cells [Biffi et. al., 2013; Rodriguez et. al., 2012], we are caught by surprise that our 
investigation shows that R-loop formation is also greatly increased in Pyridostatin-treated 
cells (Figures 17a and 18a), indicating that these structures maybe modulated in response to 
DNA damage. Collectively, the data prompted us to look into the roles of R-loops and G4 
formations in Top1cc-dependent damage pathway.  
Tyrosyl-DNA phosphodiesterase 1 (TDP1) having a role in the resolution of single strand 
breaks induced by Top1 by hydrolyzing the phosphodiester bond between the DNA 3’-end 
and the Top1 tyrosyl moiety. Studies have shown that TDP-1 together with Top1 is 
responsible in several neurodegenerative diseases such as Huntington disease and mytonic 
dystrophy type 1, implicated by expanded trinucleotide repeats. Small interfering RNA 
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(siRNA)-mediated knockdowns shows that the Top1-TDP1-SSBR (single strand break) 
pathway is required to modulate the contraction of these repeats [Hubert et. al., 2011].   
In order to study the role of R-loops and G4 structures in Top1cc-dependant repair pathway, 
we inhibited tyrosyl-phosphodiestrase 1 (TDP-1) using a TDP-1 inhibitor. Although, we 
have not obtained a similar kinetics as seen in the formation of R-loops and G4, we show 
that prolonged TDP-1 inhibition show a small changes in their formation, if any. Although 
further experiments need to be performed to establish whether or not TDP1 has any role in 
G4 and R loop formation, (particularly, assessment is needed to look at the effects of TDP1 
inhibitor on G4 and R- loop levels induced by CPT and pyridostatin), existing studies have 
been shown independently for their roles in genome instability. In non-proliferating primary 
neurons, it has been recently shown that transcription arrest by stalled Top1ccs activates the 
DSB-ATM-DDR (DNA damage response) pathway which induces the formation of γH2AX 
foci [Sordet et. al., 2009]. By blocking Top1 activity, CPT may promote an increase of local 
negative supercoiling behind the transcriptional machinery thus stabilizing R-loops, which 
may increase genome instability [Sordet et. al., 2009]. Rodriguez et. al. (2012) on the other 
hand, shows that treatment with Pyridostatin stabilizes G4 structures, generates DNA 
damage at specific genomic loci (as seen in the formation of γH2AX foci), leading to cell 
cycle arrest and transcriptional downregulation of several genes that contains PQS clusters. 
Pyridostatin also decreases proliferation of simian virus (SV40)-transformed MRC-5 human 
fibroblasts (MRC-5–SV40 cells) and various cancer cell lines.  
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